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PROSPECTIVE STUDY OF INCIDENCE OF ACUTE RENAL FAILURE IN PRETERM 
BABIES IN A TERTIARY CENTER IN SOUTH INDIA 
 
Introduction 
Acute kidney injury (formerly known as acute renal failure) is a condition where there is loss of 
excretory function of the kidney.  This leads to various complications due to accumulation of 
nitrogenous wastes.  This in turn may lead to multi-organ dysfunction.  Various studies have been done 
in different populations showing the incidence of acute kidney injury in various conditions and age 
groups.   
  Incidence of acute renal failure has been reported in different studies in various countries.  The 
incidence varies from 3.4 to 24% across various countries.  Of these, pre-renal type was found to be 
most common.   There is no definite data available on incidence of renal failure in Preterm babies in 
India.  Being a Tertiary care center in South India, our Neonatal intensive care unit is also a referral 
center and has a high turnover of preterm babies. 
   Preterm babies were chosen for this study as they are a vulnerable population and are exposed to 
various risk factors; predisposing them to multi-organ injury.  Due to the myriad of complications 
preterms are exposed to in the early weeks and multiple interventions with prolonged hospitalization, 
these babies are predisposed to acute kidney injury and its long term consequences. Factors 
predisposing to acute kidney injury are usually multifactorial.  The most common among these being 
perinatal  asphyxia and sepsis.  Both these factors are common in preterm babies. 
  In addition to these, incomplete nephrogenesis also increases the risk of renal failure in preterm 
babies compared to term babies.  Diagnosis of acute kidney injury in this population is difficult as non-
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oliguric renal failure is more common and by the time oliguria sets in, significant renal injury has 
already taken place.  This brings the role novel biomarkers like urine NGAL which has been proved to 
be useful in diagnosing acute kidney injury in other situations and age groups.   
  This study was conducted to look at the prevalence of acute kidney injury in preterm babies and also 
the various risk factors which may pre-dispose to renal injury.  Serial monitoring of creatinine and 
urine output   was done weekly. The usefulness of urinary NGAL as an early marker of renal injury 
was assessed. Follow up of the   same population to look at residual impaired renal function was 
planned. 
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                                        REVIEW OF LITERATURE 
Acute kidney injury (formerly known as acute renal failure) is a condition where there is loss of 
excretory function of the kidney.  This leads to various complications due to accumulation of 
nitrogenous wastes.  This in turn may lead to multi-organ dysfunction.  Various studies have been done 
in different populations showing the incidence of acute kidney injury in various conditions and age 
groups. 
Incidence of acute renal failure in preterm babies has been reported in different studies in various 
countries.  The incidence varies from 3.4 to 24% across various countries.  Of these, pre-renal type was 
found to be most common. (1) 
Acute kidney injury (formerly known as acute renal failure) is a complex disorder.  Various risk factors 
predispose different populations to renal injury and the severity also differs depending on the damage 
that has occurred.   
 
ETIOLOGY OF ACUTE KIDNEY INJURY 
Renal failure has been broadly divided into 3 types -  pre-renal, intrinsic renal and post-renal causes. 
Pre-renal causes include those where there is decreased blood flow to the kidneys.  It is either due to 
volume loss, hypotension and ischemia. These include dehydration, acute blood loss, sepsis, 
hypoalbuminemia and cardiac failure. 
Intrinsic renal causes may be due to a localized condition or as a part of systemic disease.  This 
includes Glomerulonephritis, Hemolytic uremic syndrome, Henoch Schonlein purpura, Acute tubular 
necrosis, Rhabdomyolysis and Tumor lysis syndrome. 
Post-renal causes lead to obstructive uropathy. The obstruction may be at any level and may be 
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congenital or acquired.  These include posterior urethral valve, ureteropelvic/vesicopelvic obstruction, 
ureterocele, tumour, neurogenic bladder and renal calculi.  
Etiology is important as management depends on the cause. In children, the most common cause of 
renal failure is glomerulonephritis.  In neonates, it is commonly pre-renal and most often associated 
with asphyxia and sepsis. 
Studies in Children were done as early as 1970s. Griffin etal described the etiology, clinical features, 
management and outcome of acute renal failure in 25 children under 2 years of age. Hemolytic uremic 
syndrome was found to be the common cause. Structural anomalies, septicemia and presumed acute 
tubular necrosis were the other causes. Mortality rate was 12% and 60% required dialysis as mode of 
renal replacement therapy.  (2) 
A Jordanian retrospective study looked at etiology and mortality in neonatal AKI. This was a multi-
center retrospective study which considered oliguria along with serum creatinine and blood urea 
nitrogen levels for diagnosing AKI. Neonatal asphyxia was the most common (40%) cause of mortality 
and was associated with oliguria. Cumulative mortality rate was 45% in the absence of dialysis.  (3) 
Mortazavi etal looked at medical records of 151 neonates with AKI. Perinatal asphyxia, sepsis, hyaline 
membrane diseases were the major causes of AKI. Mortality rate was 20.5%. (1) 
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Table 1: Causes of renal failure (4) 
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Pathophysiology of acute renal failure 
Among the different types it is pre-renal causes which commonly lead to renal failure in the acute 
setting.  In the general population, this is mostly seen in sepsis with multi-organ dysfunction; in 
children with acute gastroenteritis and dehydration and in newborn with asphyxia/sepsis. 
 
 
 
 
Figure 1: Summary of the various conditions which cause either generalized or localized reduction in 
blood flow to the kidneys.  (5) 
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Figure 2: The various stages of kidney injury. Initial reversible injury only leads to loss of brush 
border. If not treated, there is inflammation leading to necrosis and apoptosis. This may lead sloughing 
of cells and obstruction.  There is also dedifferentiation and proliferation which replaces normal 
epithelium and affects renal function.  (6) 
Injury at the cellular level 
The endothelial and smooth muscle cells play a major role in acute kidney injury. The renal blood flow 
has to be affected dramatically to cause acute renal failure.  However, what is commonly seen is 
decreased renal blood flow regionally which leads to impaired function.  The role of endothelial cells 
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is to maintain vascular tone, leukocyte function and smooth muscle responsiveness. 
When there is endothelial injury, there is vasoconstriction at arteriolar level in response to the various 
mediators that are released (endothelin – 1, angiotensin II, thromboxane A2, prostaglandin H2, 
leukotrienes C4 and D4, adenosine) and the sympathetic nerve stimulation.  Acetylcholine, bradykinin 
and nitric oxide cause decreased vasodilatation. Vasoactive cytokines and endothelin worsen the 
vasoconstriction worsening the ischemia. Endothelial-leukocyte interaction activates the coagulation 
cascade and along with vasoconstriction results in regional ischemia (most commonly affects the outer 
medulla). Proximal tubules are thereby more injured and there is inadequate sodium reabsorption. The 
macula densa senses this and there is also a functional arteriolar vasoconstriction at the pre-glomerular 
level.  Ultimately, all this leads to decreased glomerular filtration.  The endothelial injury also leads to 
increased microvascular permeability.  This in turn leads to interstitial edema. 
Tubular cells are passively injured but they also a play a major role in injury by secreting various 
cytokines and chemokines.  White blood cells – neutrophils, monocytes and macrophages aggravate 
ischemic injury by producing protease, myeloperoxidase, and reactive oxygen species.  They increase 
vascular permeability and reduce cellular integrity of both tubular epithelial and endothelial cells 
When there is severe injury, the viable and non-viable cells are desquamated and excreted as casts in 
the urine.  These casts are hallmark findings in acute renal failure.  The casts may obstruct the tubules 
and increase intra-tubular pressure, worsening injury. 
When there is AKI, a number of molecules are activated.  Of them, KIM-1 (Kidney injury molecule 1) 
and neutrophil gelatinase associated lipocalin were found to be elevated.  Both seem to have a role in 
limiting immune response in AKI.  Their levels increase early in injury and may be useful in diagnosis 
of AKI. 
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Figure 3: Cellular pathophysiology of acute kidney injury  
Repair of epithelium 
Normally, when the kidney recovers from the insult, the epithelial cells which were lost will be 
replaced by surviving cells.  Surviving cells dedifferentiate, migrate along the basement membrane, 
multiply and restore the functional integrity of the nephron. 
The normal repair need not occur in every case.  In some cases, there is progression of AKI to chronic 
kidney disease.  There are maladaptive changes instead of structured repair leading to fibrosis, 
incomplete tubular repair, persistent tubulo-interstitial inflammation, fibroblast proliferation and 
excessive deposition of extracellular matrix.  If there is long term hypoxia, there is sustained loss of 
peri-tubular vessels and chronic fibrosis. 
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ACUTE KIDNEY INJURY IN PRETERM BABIES 
Acute renal failure is characterized by sudden onset of impaired function, which leads to retention of 
nitrogenous wastes, and there is dysregulation of extracellular fluid, acid base homeostasis and 
electrolyte imbalance.  (7) 
ETIOLOGY OF ACUTE KIDNEY INJURY 
Factors leading to acute renal failure may be broadly divided into 3 sub-categories – pre-renal, renal 
and post renal. 
Pre-renal azotemia:  This is due to decreased blood flow to the kidney. 
Decreased blood flow to kidney may be seen due to: 
1. Dehydration – increased loss like in diarrhea, increased trans-epidermal loss of free water, post 
operative in gastro-intestinal surgeries or chest tube losses 
2. Blood loss compromising circulatory volume – fetomaternal hemorrhage, perinatal blood loss 
3. Capillary leak (infection, hydrops fetalis and low albumin levels) 
4. Increased abdominal pressure (post-operatively in gastroschisis, omphalocele, congenital 
diaphragmatic hernia; ascites and necrotizing enterocolitis) 
5. Decreased Cardiac output (cardiac failure) 
6. Drugs affecting renal perfusion (Indomethacin and ACE inhibitors) 
Renal causes of acute renal failure range from congenital to acquired causes 
1. Acute tubular necrosis (may be due to severe ischemia or toxins) 
2. Infections (localized to the kidneys or part of severe systemic infections) 
3. Vascular causes – renal artery or venous thrombosis 
4. Nephrotoxic drugs like Aminoglycosides, Indomethacin, Amphotericin B, radio-contrast dyes 
and acyclovir 
5. Congenital malformations like renal agenesis, dysplastic or polycystic kidneys 
 21 
Post renal or obstructive causes 
These may be congenital or acquired; intrinsic or extrinsic obstruction.   
It includes obstruction at various levels – prepuceal, urethral stenosis, posterior urethral valve, pelvi-
ureteral junction obstruction. 
Extrinsic obstruction may be due to sacrococcygeal teratoma or hematocolpos. 
AKI IN PRETERM BABIES 
 Preterm babies differ from the rest of the pediatric population.  They are a more vulnerable population 
and are prone organ injury.  The reason they are more prone to multi-organ injury is due to their 
immature immune system and incomplete organogenesis.   
Higher incidence of asphyxia and occurrence of hyaline membrane disease, intra-ventricular 
hemorrhage, patent ductus arteriosus, sepsis and effects of nephrotoxic drugs like aminoglycosides and 
NSAIDS predispose them to multi-organ injury.  Nephrogenesis is complete only by 34 weeks.  So any 
preterm baby born before 34 weeks has an immature renal system and being at a higher risk for 
ischemia, hypovolemia and hypotension; they will be more prone to acute kidney injury.  Most 
common is pre-renal type of renal failure (8) 
In the US, premature birth incidence rate was 12.8% of all live births.  Risk factors include increasing 
maternal age, IVF pregnancies, multifetal pregnancies; complications like PIH, use of tobacco and 
alcohol were some of the contributing to preterm birth in addition to spontaneous preterm labour.  (9) 
Primiparity, poor socio-economic status, lower educational status and poor maternal nutritional status 
were found to be some of the predisposing factors to preterm labour by Fathima etal in a study in India 
(10) 
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RISK FACTORS IN PRETERM BABIES PREDISPOSING TO AKI 
Asphyxia is a common risk factor in preterm babies which leads to hypoperfusion and increases risk 
of AKI. It accounts for almost one third of all asphyxiated babies and the mortality rates are high in 
view of other risk factors associated with prematurity.  (11) Prematurity – lower the gestational age 
and birth weight, mode of delivery – Caesarean section are some of the factors associated with 
increased risk of resuscitation at birth. (12) 
Hyaline membrane disease (otherwise known as Respiratory distress syndrome) is the most common 
complication seen in preterms. There is higher incidence of HMD in Mothers with PIH. (13) With the 
use of antepartum steroids, non-invasive ventilatory techniques and surfactant use, the incidence of 
complications following HMD has decreased over the years. The incidence is as high as 28% in a few 
centers. (14) 
Sepsis, both early and late onset sepsis is higher in preterms. With use of intra-partum antibiotics, the 
infection rates have drastically dropped in the West. Hypotension and hypoperfusion associated with 
sepsis increases the risk of renal failure. (15) 
Necrotizing enterocolitis is a disease of preterm which affects the gut. It is often associated with 
multi-organ dysfunction. A New South Wales study showed decreasing trend of NEC following the use 
of antepartum steroids, early enteral feeding and gradual grading up of feeds.  The incidence of NEC 
was 5% in this group. (16) 
Other risk factors include use of nephrotoxic drugs like Indomethacin, aminoglycosides, etc. Renal 
failure is mostly reversible following drugs toxicity. Documented renal failure following Indomethacin 
is often seen but the long term renal function was found to be normal. (17) 
The global incidence of AKI in neonates ranges from 3.4 to 24%.  (1) There is no data available on 
incidence of neonatal AKI in the Indian setting.  There were few studies done in the India on 
asphyxiated neonates.  Ashraf etal looked at 80 asphyxiated neonates born during March 2006 and 
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February 2007.  In Srinagar, these 80 babies were thoroughly examined after getting detailed history.  
Investigations done included urine examination, serum electrolytes, creatinine, urea, uric acid, 
ultrasonography of the abdomen and cranium.  AKI was seen in 45% of them- non oliguric type was 
seen in 77%.   Mortality rate was 11.1% and ultrasonography in the acute setting showed increased 
echogenicity of kidney in all of them. (18) A case control study done by Gupta etal in Rajasthan where 
70 asphyxiated neonates and 28 healthy neonates were recruited.  Asphyxia was defined as Apgar 
score less than 7 at 5 minutes.  Urine microscopy, serum creatinine and urea were done for all babies.  
Oliguria (urine output <0.5 ml/kg/hour), Creatinine > 1mg/dL and urea > 40 were the criteria required 
to define AKI. AKI was seen in 47.1% and non-oliguric AKI was found in the majority of the (78%).  
Those with severe asphyxia had oliguria.   The mortality rate was 7.1% which were asphyxia related.  
The survivors were followed up at 1 and 6 months and none of them had residual renal dysfunction.  
(19) 
 
NEPHROGENESIS 
The fetal kidney develops from three successive mesodermal structures which are pronephros, 
mesonephros and metanephros.  Metanephros arises from the ureteric bud (branch of Wolffian duct).  
Interaction between metanephric mesenchyme and ureteric bud epithelium lead to “branching 
morphogenesis” which leads to formation of collecting system.  Differentiation of metanephros occurs 
only by 5 weeks.  First nephrons are formed only by 8 weeks and nephrogenesis is complete only by 
34 weeks.  Nephrons grow in size from 35 weeks till birth.  (20) 
Kidney weight increases with gestational age towards the latter half of pregnancy.  Renal architecture 
may be appreciated as early as 20 weeks.  The ratio between renal and abdominal circumference at the 
level of umbilical vein remains constant (0.27 to 0.30). 
As nephrogenesis is incomplete in those born prior to 34 weeks, it has been proposed that they have a 
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lesser renal volume and the function may also be impaired. In addition to this, the risk factors they are 
exposed to possibly worsen the renal function.  Therefore it is important to detect acute kidney injury 
in neonatal period.  It is also important to follow up these babies and monitor growth, blood pressure 
and renal function as they may be at risk for chronic kidney disease. (21) 
 
Figure 4: Nephrogenesis 
Functional status of the kidneys in older children and adults can be assessed by monitoring urine 
output and serum creatinine levels.  This cannot be done in neonates due to various reasons.  
Creatinine measured within 72 hours reflects maternal creatinine values.  In fact, this may persist as 
long as 15 days in preterm babies.  The other factors which determine creatinine level include muscle 
mass, age, hydration status and gender.  In view of which, it may not be the ideal diagnostic tool for 
assessing renal functional status.  
A recent Serbian study published in 2014 was conducted in University of Novi Sad by Stojanovic etal, 
retrospectively looked at 150 preterm babies born before 37 weeks of gestational age. All babies had 
baseline creatinine done on day 3 of life followed by everyday or every other day monitoring of 
 25 
creatinine for the first 7 days. If there was any deterioration, creatinine monitoring was done for atleast 
48 hours following the deterioration. In this study, AKI was defined as creatinine more than 0.3 mg/dL 
compared to baseline values or compared to the ones done 48 hours prior. Urine output was also 
monitored. Staging of disease was by modified AKIN criteria into 3 stages. Antenatal factors like PIH, 
Diabetes, antibiotics and chorioamnionitis in the Mothers were looked at. Gestational age, birth-
weight, Apgar score, temperature at admission, serum lactate, serum pH, ventilation, use of 
nephrotoxic drugs, inotropes and maximum FiO2 requirement was analysed. 
AKI incidence was 26%. It was more common in those with birth-weight less than 1500 Gm (94.8%) 
and gestational age less than 28 weeks (64.1%). Non-oliguric renal failure was common (60%) than 
oliguric (25%) or anuric (15%) renal failure. Metabolic acidosis was more pronounced in those with 
AKI. All of them were on assisted ventilation with higher oxygen requirement. Certain complications 
like intracranial hemorrhage, necrotizing enterocolitis, sepsis and PDA were more common in the AKI 
group and statistically found to be independent risk factors for AKI. In one third of them, creatinine 
normalized and they survived. Despite normalized creatinine, 7.7% died. Creatinine remained high in 
59%. Mortality rate was found to be high (69.2%) in the AKI group – highest in stages 2 and 3 AKI 
and in those with birth-weight less than 1500 Gm. They concluded that AKI was a major problem in 
preterm babies and it is important to identify it early to initiate prompt treatment. (22) 
 Over the past many years, various biomarkers have been found to be useful in determining acute renal 
injury.  These have been used in different age groups with various risk factors and complications.  
They have been found to be useful in determining renal damage at the risk and injury level; even 
before irreversible damage and failure has occurred. Of these, urinary NGAL has been studied 
extensively in various populations.  
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DIAGNOSIS OF AKI 
CLINICAL HISTORY AND EXAMINATION 
A detailed history and thorough clinical examination will help diagnose the type of renal failure and 
treat appropriately.  The age of the patient, drug history, past history and family history give important 
clues to etiology.   
Universal definition of acute kidney injury was not available till 2004 when Nephrologists and critical 
care groups came up with the RIFLE criteria.  RIFLE stands for Risk, Injury, Failure, Loss and End 
stage renal disease.  This is applicable to adult population.  (23) 
 A modified Pediatric RIFLE criterion was proposed based on estimated creatinine clearance. (24) 
The modified Pediatric RIFLE criteria may not be helpful in preterm babies.  However, the concept of 
RIFLE helps us understand the importance of detecting kidney damage at risk or injury rather than at 
failure stage when significant renal damage has occurred and may progress to loss of function and 
even end stage renal disease.  This is depicted in figure 5.  This throws light on the existence of 
biomarkers which help detect kidney damage at earlier stages. 
 
 
 
 
 
 
 
 
 
 
Fig 5: RIFLE criteria 
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AKIN (Acute Kidney Injury Network) has a criteria similar to the RIFLE which is based on 
creatinine and urine output.  ADQI (Acute Dialysis Quality Initiative) introduced the RIFLE criteria in 
2004. (25) 
Later in 2008, the AKIN group came with their criteria. This was based on the evidence that small rise 
in creatinine is associated with adverse outcomes. A rise of more than 0.3 mg/dL and a time constraint 
of 48 hours was used. (26) It was later found in a multicenter trial which looked at 59 ICUs across 
Australia-New Zealand that there was no advantage of one criteria over the other. (27) 
Figure 6: AKIN criteria 
 
 
 
 
 
Figure: 7 Pediatric – Modified RIFLE criteria 
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The significance of RIFLE criteria is timely intervention and preventive measures may help salvage 
renal function.  When a vulnerable patient has been identified, avoiding nephrotoxic drugs and volume 
resuscitation or inotropic support may help prevent renal failure.  If adequate measures are not taken, 
the patient may go into renal failure requiring dialysis or even end stage renal disease. 
LAB INVESTIGATIONS 
Even before creatinine or novel biomarkers of acute kidney injury, something as simple as urine 
examination will give us a clue about ongoing kidney injury.  Urine analysis showing red blood cell 
casts is suggestive of glomerulonephritis, while cola coloured urine with high myoglobin levels is 
suggestive of rhabdomyolysis - which may predispose to acute tubular necrosis if there is no 
intervention at this point. 
Urine indices like urine osmolality, urinary sodium levels and fractional excretion of sodium help 
differentiate between pre-renal and renal failure. (28) 
In case of obstructive causes, it is important that imaging is done (atleast ultrasonography) because just 
urinary catheterization may relieve the obstruction and help resolve renal failure. 
Creatinine as a marker of kidney injury 
Creatinine is a breakdown product of creatinine phosphate in the muscle.  It is produced at a fairly 
constant rate in the body and depends on muscle mass.  Other factors which influence creatinine levels 
include age, gender and hydration status. 
Creatinine metabolism: 
Creatinine is synthesized in the liver by methylation of glycocyamine by S-adenosyl methioinine.  It is 
transported through blood to various organs including muscle and brain.  In these organs, it is 
phosphorylated to form phosphocreatine.  (29) 
The kidneys excrete creatinine mainly by glomerular filtration and also by proximal tubular secretion.  
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As creatinine is hardly reabsorbed, it reflects the glomerular function.  In other words, blood and urine 
creatinine levels can be used to calculate creatinine clearance which reflects the glomerular filtration 
rate (GFR).  The GFR measures renal function. 
Factors affecting creatinine levels 
Men have more muscle mass than women and children.  Therefore, tend to have higher creatinine 
values.  Similarly, older children have more muscle mass and creatinine levels tend to be higher.   Meat 
intake may alter the creatinine levels as well. (30)    
 In term neonates, creatinine levels in the first 72 hours reflect maternal levels.  In preterm babies, this 
may persist even up to 15 days.  Gestational age, weight, muscle mass and hydration status determine 
creatinine levels in this population.  Pre-renal causes and non-oliguric renal failure being more 
common, acute kidney injury may not be easily diagnosed in this population. (31) 
Methods of measuring creatinine level 
Jaffe reaction was first described in 1886.  Max Jaffe found that when mixed with sodium hydroxide 
solution, creatinine forms a reddish orange colour and the level of creatinine can be measured by 
colorimetric methods.  This test has undergone various phases and currently done after IDMS (isotope 
dilution mass spectrometry) calibration. (32) Other methods use enzymatic methods - creatinase, 
creatinine deaminase and isotope dilution mass spectrometry. 
Estimation of renal function by creatinine clearance: 
The serum creatinine levels depend on various factors.  Therefore, an absolute value of creatinine may 
not reflect the actual renal function.   It was later found that creatinine clearance helps estimate the 
GFR and renal function. Creatinine clearance may be estimated by various formulas.  (30) 
Schwartz equation: 
Cr Cl (ml/min/1.73m²) = [length (cm) x k] / S Cr 
This can be used in infants over 1 week to adolescents 18 years of age 
K = 0.45 for infants 1 to 52 weeks,  
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K = 0.55 for children 1 to 13 years, 
K = 0.55 for adolescent girls 13 to 18 years 
K = 0.7 for adolescent boys 13 to 18 years 
CREATININE IN NEONATES 
In term neonates, creatinine levels in the first 72 hours reflect maternal levels. In preterm babies, this 
may persist even up to 15 days. Gestational age, weight, muscle mass and hydration status determine 
creatinine levels in this population. Pre-renal causes and non-oliguric renal failure being more 
common, acute kidney injury may not be easily diagnosed in this population (29). 
Boer etal looked at creatinine levels done in infants less than one year of age during the period 2003 
and 2008 and came up with reference values for creatinine. (33) Different studies have taken different 
cut-off values of creatinine to define AKI. An Italian case-control study by Cataldi etal studied 
potential risk factors leading to AKI in preterm babies. Creatinine value of more than 1.3 mg/dL in 
babies born at less than 33 weeks and more 1 mg/dL in those > 33 weeks of gestational age was used 
to define AKI. (34) 
Kapoor etal reported incidence of AKI in Maulana Azad medical college, New Delhi based on 
creatinine and oliguria in a retrospective study. Absolute value of creatinine more than 1.5 mg/dL was 
taken to define AKI and incidence was found to be 9.6%. Most common predisposing factor was 
sepsis (61.3%) followed by asphyxia (22.7%). Both term and preterm babies were included in the 
study. Pre-renal failure was identified as most common type of renal failure (50%). Mortality rate was 
15.9%. (35) 
Stojanovic etal took a rate of rise in creatinine rather than an absolute value to define AKI in preterm 
babies. A rise of more than 0.3 mg/dL was taken to define AKI (22). 
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NOVEL BIOMARKERS IN DETERMINING ACUTE KIDNEY INJURY  
There are many biomarkers now available which are found to be useful in determining acute renal 
injury.  The urinary biomarkers are found to rise just hours after the insult has occurred and help us to 
intervene even significant irreversible injury has occurred.  Creatinine rise is found to occur 48 hours 
after significant injury has occurred and intervention may or may not help salvage the renal function.  
 
 
 
 
 
 
 
 
Table 2: Gold standard diagnostic tools in myocardial injury versus kidney injury  
Discovery of Troponin has improved mortality and morbidity rates in myocardial injury. Timely 
intervention has helped salvage lives.  It is important to have Troponin like markers where timely 
intervention can prevent irreversible injury in the kidneys.  The only marker available was creatinine. 
 Unfortunately creatinine is not a marker that increases so early in injury.  Significant injury (25 to 
50%) has already occurred by the time creatinine rise is seen.  It also depends on the method used to 
estimate creatinine level.  In certain population like newborn, high bilirubin may interfere with 
estimating creatinine.   (29) 
  Over the past decades, a lot of research has gone into finding other markers for renal injury.  Different 
biomarkers were discovered over a course of time. Urinary biomarkers have been used in the past for 
detecting renal injury in various situations and age groups including newborn babies post-cardiac 
surgery.  
    YEAR         MYOCARDIAL INJURY MARKER               RENAL INJURY MARKER 
     1960                 Serum LDH                                                    Serum creatinine  
     1970                 CPK, myoglobin                                             Serum creatinine  
     1980                 CKMB                                                            Serum creatinine  
     1990                 Troponin T                                                      Serum creatinine  
      2000s               Troponin I                                                       Serum creatinine  
      
     Outcome           Multiple therapies                                           Supportive care  
                               50%↓ in mortality                                           High mortality rates       
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 There are many biomarkers available but extensive research studies are required to prove their 
usefulness in preterm babies.  Some of these include neutrophil gelatinase associated lipocalin 
(NGAL), Interleukin 18 (IL-18), kidney injury molecule -1 (KIM-1), Osteopontin (OPN), beta 2 
microglobulin (B2mG) and Cystatin C (Cys-C).  
PHASES OF DEVELOPING A BIOMARKER  
There are five phases for development of a biomolecule.  Pre-clinical discovery, development of an 
assay, use of assay retrospectively and compare with existing tests, prospective screening to prove its 
efficacy and finally disease control. (36) 
NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN 
Lipocalin -2 (LCN2) also known as oncogene 24p3 or neutrophil gelatinase associated lipocalin is a 
protein.   It is encoded by LCN2 gene.  As the name suggests, it is expressed by neutrophils and in low 
levels by kidney, prostate and epithelia of the respiratory and gastro-intestinal tract.  It is a 25kDa 
protein covalently bound to neutrophils.  Originally, it was isolated from supernatant of activated 
human neutrophils and therefore the name.  It was later found to be elevated in conditions even when 
neutrophil counts were not high.   
The distal tubules and various other organs produce NGAL but it is reabsorbed in the proximal tubules. 
It is an iron transporting protein.  Iron has been hypothesized to protect proximal tubule.  NGAL was 
found to inhibit apoptosis, enhances proliferation and provide functional as well as pathological 
protection in rat models. It was also found to bind to bacterial siderophobes and rendering innate 
immunity against bacterial infection.  It limits bacterial overgrowth by sequestering bacterial 
siderophores. (37) 
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Figure 8:  Molecular role of NGAL 
 
ROLE OF NGAL IN ACUTE KIDNEY INJURY  
NGAL was found to be elevated in the urine 2 to 4 hours after renal injury.  Normally, NGAL reaches 
proximal tubules after glomerular filtration.  It is reabsorbed into the systemic circulation via megalin. 
Therefore, there is a very low NGAL level in the distal tubules and only trace amounts will be excreted 
in the urine.  When there is acute kidney injury, the proximal tubules are unable reabsorb the high 
levels of NGAL.   
In addition to this, the distal tubules also secrete NGAL.   So the urine level of NGAL is elevated in 
acute kidney injury. (Figure 9) (6) 
 34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 9: NGAL in acute kidney injury 
The reason why NGAL was chosen over other biomarkers is because it fulfills most of the criteria for 
an ideal test. (6) 
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Table 3: Properties of NGAL 
 
Studies on NGAL IN AKI: 
There are studies carried out at various phases for developing NGAL as a biomarker for AKI.  Most of 
these studies were conducted by Devarajan etal, a Cincinnati group whose pioneering work on this 
biomarker is extensive and revolutionized approach to AKI. 
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Preclinical phase 
Supavekin etal conducted studies on mouse models to look at differential gene expression following 
renal ischemia /reperfusion. Mice unilateral renal artery clamping for 45 minutes to induce renal 
ischemia and were sacrificed at 0, 3, 12 and 24 hours to look for reperfusion. They found tubular cell 
apoptosis using DNA laddering and TUNEL assays.  CDNA microarrays were used to identify genes 
expressed. Along with pro-apoptotic factors, growth factors signal transduction and transcription 
factors were also expressed. (38) Kiyoshi etal used a mouse model to show that NGAL rescues kidney 
from ischemic injury.  NGAL was introduced into mice with severe renal injury (during the early 
stages) and found that it dramatically protects the kidney and mitigates azotemia. (39) Experiments by 
Mishra etal in-vitro cultured human proximal tubular cells found that NGAL levels increasing in both 
unilateral as well as bilateral renal injury.  It was also found that level of NGAL rise was directly 
proportionate to duration and dose of renal ischemia.  Mild perfusion injury to the cultured human 
proximal tubular cells also leads to increase in NGAL levels. (40) 
Clinical studies 
Most clinical studies were done in post-cardiac surgery, critical care and post transplant patients (liver 
and renal transplant. (41) A cross-sectional study in human subjects admitted in intensive care unit 
with established acute renal failure.  NGAL levels were found to be 10 folds higher in the plasma and 
100 folds higher in the urine in these subjects when compared to plasma and urine levels in normal 
subjects.   This study by Mori etal   high NGAL also correlated with high creatinine.  Renal biopsy 
done showed immuno-reactive NGAL in more than 50% of the cortical tubules. (39) 
Zapitelli etal conducted studies on critically ill children (from one month to twenty one years of age).  
They found that NGAL rise was seen early in AKI in those who manifested a significant rise in 
creatinine only after 48 hours.  They concluded that NGAL was useful in detecting early kidney injury 
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but not of much use once the creatinine levels have started rising. (42) Children undergoing cardio-
pulmonary by pass surgery were studied by Dent etal.  In this cross sectional study, multiple samples 
of NGAL was taken post surgery.  AKI was defined as 50% or greater rise of creatinine.  It was again 
found that NGAL rise was seen early (within hours) when compared to creatinine which increased 
only after 1 to 3 days. (43) Similar study was done by Koch etal in children post cardiac surgery for 
congenital heart disease showing NGAL as useful biomarker for AKI. (44) 
A prospective study on role of NGAL being a biomarker of acute renal injury following cardiac 
surgery was done by Misra etal where all post cardiac surgery patients during the period January to 
November 2004 were enrolled.  Urine and serum NGAL was monitored in these patients along with 
urine output and creatinine levels.  ELISA and immunoblot techniques were established with 
commercially available antibodies. It was found that NGAL rise was much earlier during AKI 
compared to creatinine rise.  NGAL level rose hours after an insult whereas a significant rise of 
creatinine was seen only after 48 hours. (21) Nieman etal described use of NGAL in post liver 
transplant subjects. It was found that the rate of rise of NGAL rather than a single value was useful in 
predicting those at higher risk of AKI. Creatinine was monitored daily and RIFLE criteria as used to 
define AKI. (46) All the mentioned studies used serial monitoring of plasma or urine NGAL and it was 
found that NGAL is a promising troponin like marker in AKI.  This may help decrease morbidity and 
mortality in patients with AKI.   
NGAL IN NEONATAL AKI 
Extensive studies on this biomarker have been done by the Cincinnati group (Devarajan etal).  Initial 
studies were to look at the normal trend of NGAL in preterm low birth weight babies.  The urine 
NGAL level was found to be inversely proportional to gestational age and birth weight.  (47) 
This study did not look at NGAL as a marker of AKI. An Egyptian cohort study on asphyxiated babies 
showed elevated serum NGAL to be an early marker predicting AKI. (48) 
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Most studies used creatinine and urine output as gold standard to study NGAL. Creatinine reference 
values in the first year were extensively studied by Boer et al (33).  
There is need for more data to analyse the usefulness of NGAL as a biomarker of AKI in neonates. 
Preterms are particularly susceptible as they are exposed to several risk factors which may predispose 
to renal injury and long term consequences. Early detection will help to decrease long term morbidity 
and adverse outcome. This study was thus planned with the hope that it will provide important 
guidelines on monitoring of preterm babies for kidney injury. 
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AIMS AND OBJECTIVES 
 
The purpose of this study was to determine incidence of acute renal failure in preterm babies born in a 
tertiary care center and its outcome  
AIM:  
To study the incidence of acute renal failure in inborn Preterm babies at a tertiary care center in South 
India 
OBJECTIVES 
Primary objectives: 
1. To determine incidence of acute renal failure in preterm neonates 
2.  To study risk factors pre-disposing to renal failure  
Secondary objectives: 
1. To evaluate the usefulness of Biomarkers like NGAL as marker of renal functions and 
predictors of acute kidney injury in preterm babies. 
2. To study renal outcome of preterm babies at 6 months 
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MATERIAL AND METHODS 
STUDY DESIGN: 
Descriptive study looking at incidence of acute renal failure in preterm babies 
STUDY SETTING: 
Christian Medical College is a tertiary care center situated in Northern part of Tamil Nadu.   
This study was conducted in Neonatal intensive care unit as collaboration between Departments of 
Neonatology and Pediatrics unit II during the period - May2014 and August 2014.  During the study 
period, babies born at less than 32 weeks of gestational age were recruited for the study.  Those babies 
with abnormal antenatal renal scans, major systemic congenital anomalies and chromosomal anomalies 
were excluded.  
SAMPLE SIZE:  
Sample size was calculated based on incidence of renal failure. Incidence of renal failure worldwide 
ranges from 3.4 to 24% as mentioned in an Iranian study. Assuming that incidence of renal failure in 
our population is 10% with a precision of 6% and confidence interval of 95%, sample size was 
calculated to be 96.  
Estimating single proportion (Absolute precision)  
Assumptions 
 The outcome variable measure should be binary (success/failure, alive/dead)  
 p is probability of success in each trial; (1-p) is probability of failure  
 The sampling distribution of the sample proportion (p) is approximated to normal.  
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Expected Proportion 0.1 
Precision (%) 6 
Desired confidence level (1- alpha) % 95 
Required sample size 96 
  
Note: Based on the incidence (3.4 to 24)%of renal failure among the preterms as quoted in Iranian study. 
 
All those babies who fulfilled the inclusion Criteria and had none of the Exclusion criteria were 
recruited.   After counseling the parents and getting consent from them, the study proformas were filled 
in. The details included demographic data like hospital number, age, gender, gestational age, birth 
weight; maternal history- both antenatal and peri-partum period.  Neonatal history - perinatal history 
including Apgar score, resuscitation details, clinical features suggestive of sepsis, routine 
investigations and procedures which may predispose to renal failure were looked at.  
  During the hospital stay, weekly monitoring was done.  Urine output, clinical deterioration if any, 
details of interventions – long line, ventilation, any unexpected event and use of nephrotoxic drugs 
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were noted. Urine output was monitored non-invasively once a week by either urine collecting bags or 
weighing the cotton pad.   
 In case of death or the baby being discharged against medical advice, they were considered as case 
dropouts. 
Blood sampling for serum creatinine and urine for NGAL was collected once a week. Serum creatinine 
was processed in Clinical biochemistry lab of CMC Vellore using standard methods. Serum creatinine 
more than 1.3 mg/dL or more than 50% rise of creatinine compared to previous value was used to 
define AKI. Urine for NGAL was collected and stored.  Urine NGAL was processed for 30 babies as 
part of a pilot study to look if it was useful in detecting acute kidney injury in this population.  Urine 
NGAL was processed using a rapid ELISA kit (kit 037). 
 Following discharge, all babies were planned be followed up at 3 and 6 months.   At 3 months, along 
with routine clinical examination (growth monitoring, daily urine output and feeding), urine 
microscopy, serum creatinine will be checked and a sample for urine NGAL will be collected and 
stored.  At 6 months, in addition to these, ultrasound abdomen will be done to look at kidney size.  At 
follow up, if there is altered renal function on blood tests or abnormalities in ultrasound scan, these 
cases will be followed up in Pediatric nephrology. 
The data collected was statistically analysed. Descriptive statistics were reported using Mean+/- SD for 
continuous variables; Median (IQR) for non-normal variables, categorical variables were be reported 
using n and %. Repeated measures ANOVA were done for the parameters which are measured for 
various time points. Categorical variables were assessed using Chi square/Fishers exact test. 
Incidence was reported using n and %.  Risk factor analysis was done using Log binomial to estimate 
the RR.  Survival analysis was done to assess the outcome of renal failure. 
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                            FLOW CHART SHOWING ALGORITHM OF THE STUDY 
 
 
                                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preterm babies < 32 weeks of 
gestation 
 
Fulfills inclusion criteria 
Exclusion criteria:  
Major congenital 
anomalies, abnormal 
antenatal renal scan 
Excluded 
Consent 
Proforma 
Weekly monitoring for risk factors, 
interventions, drugs, urine output 
 
Weekly collection of serum creatinine 
and urine for NGAL 
Death or discharged 
against medical 
advice 
Case dropout 
Follow up visits at 3 and 6 months 
Weight gain, serum creatinine, urine for 
NGAL 
USG at 6 months to look at kidney size 
Any abnormality, to f/u 
with Pediatric nephrology 
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RESULTS 
This study was carried out in the Neonatology department in collaboration with the Pediatric unit 
of Christian Medical College Vellore during the period of May 2014 to August 2014. 
Babies born at or less than 32 weeks (up to 32+6 weeks) of gestational age were included. Those with 
major congenital anomalies and abnormal antenatal renal scans were excluded. 
Weekly monitoring of risk factors, interventions, drugs were noted.  First sample of Serum creatinine 
and urine for NGAL were collected after 72 hours of age. 
The data was statistically analysed using SPSS software, version  
 
The results of our study are depicted below. 
 
There were a total of 4823 live births during this period.  
There were 789 preterm deliveries (less than 37 weeks) (16.36%).  
Of these, 80 were preterm deliveries < 32 weeks gestation (10.14%).  
Of this group a total of 79 were recruited in the study. 
 
A total of 79 babies were recruited. Of these, three died (one within 3 days of life and two were late 
neonatal deaths) and two were discharged against medical advice and hence could not be evaluated 
completely. 
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                             DEMOGRAPHIC DATA 
 
GESTATIONAL AGE 
 
Table 1: Gestational age distribution 
Gestational age Number  (n = 79) Percentage (%) 
< 28 weeks 12 15.1 
29 to 30 week 26 32.9 
30 to 31 weeks 41 51.8 
 
 
 
Figure 1: Distribution based on gestational age 
 
There were 12 babies (15.1%) between 27 to 28 weeks, 26 (32.9%) between 29 to 30 weeks and 
between 31 to 32 weeks there were 41 (51.8%). 
27 wk – 1 
28 wk – 11 
29 wk – 4 
30 wk – 22 
31 wk – 19 
32 wk - 22 
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BIRTHWEIGHT 
Table 2: Birth weight distribution 
Birth weight (in Gm.) Number  (n = 79) Percentage (%) 
<1000      8    10.1 
1001 to 1500     45    56.1 
1501 to 2000    25    31.6 
> 2000     1    0.2 
 
 
         
Figure 2: Birth weight distribution 
More than half the babies (56.1%) had birth weight between 1001 to 1500 Gm, while a third 
 weighed   between  1500 and 2000 Gm. (31.6%). 
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GENDER 
 
Table 3: Gender distribution  
Gender Total number (n= 79) Percentage (%) 
Male 45 57 
Female 34 43 
 
Table 3: Gender distribution 
 
There were 45 males (57%) and 34 females (43%).  The male: female ratio was 1.3: 1. 
 
MALE
FEMALE
45
34
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MATERNAL AGE  
Table 4: Maternal age distribution 
Maternal age Number  (n =79) Percentage (%) 
<20 7 8.8% 
20 to 30 50 63.3% 
>30 22 27.9% 
 
 
 
Figure 4: Maternal age distribution 
 
There were 63.3%% mothers who were between 20 and 30 years , followed by 27.9% more than 30 
years and 8.8% less than 20 years. 
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MATERNAL EDUCATION STATUS 
Table 5: Educational status 
Education Number  (n = 79) Percentage (%) 
Nil 23 29.1 
Primary school 28 35.4 
High school 3 3.7 
Graduate 17 21.5 
Post graduate 8 10.1 
 
 
 
Figure 5: Maternal educational status 
 29.1% mothers were uneducated, 35.4% had primary school education. 
There were 21.5% graduates and only 10.1% postgraduates 
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ANTENATAL ULTRASOUND 
Table 6: Findings on antenatal USG 
USG findings Number (n = 69) Percentage (%) 
Normal 31 44.9 
Abnormal  12 17.3 
Twins 19 27.5 
Triplets 3 4.3 
Placenta praevia 2 2.8 
 
Figure 6: Ultrasound findings 
Of the total, 69/79 mothers had antenatal scans done. Normal scans were noted in 44.9% while 17.3% 
showed anomalies.  
There were 10 sets of twins in the study- of which one of the twins was excluded from the study in 
view of major congenital anomaly.  
Abnormal scans included abnormal Doppler and IUGR, while one baby had fetal ascites. 
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MODE OF DELIVERY 
Table 7: Mode of delivery 
Mode of delivery Number (n = 79) Percentage   (%) 
LSCS 47 59.5 
Normal 25 39.6 
Breech/instrumental 7 8.8 
 
 
 
 
Figure 7: Mode of delivery  
Most common mode of delivery was LSCS in 47 (59.5%) followed by normal delivery in 25 (31.6%) 
 and Breech/instrumental in 7 (8.8%) 
 
 
Normal LSCS
Breech/forceps  
47 
25 
7 
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PARITY OF MOTHER 
Table 8: Parity pattern 
Parity Number  (n = 79) Percentage (%) 
Primipara 56 70.8 
Multigravida 23 29.2 
 
 
Figure 8: Parity  
 
Majority of mothers were primipara - 56 (70.8%); while 23 (29.2%) were multigravida  
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MATERNAL RISK FACTORS 
Table 9: Antenatal and perinatal risk factors (Maternal) 
Risk factors Number (n =79) Percentage (%) 
PIH 31 39.2 
PPROM 18 22.7 
GDM 11 13.9 
Chorioamnionitis 5 6.3 
UTI 2 2.5 
 
 
Figure 9: Maternal risk factors 
PIH was the commonest morbidity seen in the Mothers (39.2%) followed by PPROM (22.7%).  
Other risk factors included GDM (32.9%), UTI (2.5%) and chorioamnionitis (6.3%). 
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APGAR SCORE  
Table 10: Apgar score  
Apgar score at 5 min Number Percentage 
Apgar >6 72 91.1 
Apgar < 6 7 8.9 
 
Figure 10:  Apgar at 5 minutes 
 
There were 72 babies (91.1%) with Apgar score more than 6 and 7 with Apgar less than 6 (8.8%) 
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NEONATAL RISK FACTORS AT BIRTH 
 Table 11: 
Risk factors Number  (n = 79) Percentage (%) 
Resuscitation at birth 17 21.5 
Intubation 15 18.9 
Symptomatic at birth 55 69.6 
 
 
 
Figure 11: Neonatal risk factors at birth  
There were 55 babies (69.6%) who were symptomatic at birth.  
Resuscitation was needed in 21.5% and intubation in 18.9% 
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SYMPTOMS  
Table 12:  
Symptoms Number (n= 79) Percentage (%) 
Respiratory distress 52/79 65.8 
Poor perfusion 9/79 11.3 
Abdominal distension 6/79 7.5 
Apnea 5/79 6.3 
Temperature instability 4/79 5.0 
Shock 2/79 2.5 
Oliguria 2/79 2.5 
Anuria 1/79 0.2 
Seizure 2/79 2.5 
Hypoglycemia 1/79 0.2 
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Figure 12:  Symptoms in the neonate 
 
Respiratory distress was the most common symptom (65.8%) followed by poor perfusion (11.3%). 
Others included abdominal distension (7.5%), apnea (6.3%) temperature instability, (5%), seizures 
 (2.5%), hypoglycemia (0.2%) and decreased urine output (2.5%) 
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CONDITIONS AFFECTING MORBIDITY 
Table 13:  
Condition Number  (N = 79) Percentage (%) 
Hyaline membrane disease 33/79 41.7 
Sepsis 24/79 30.3 
Necrotizing enterocolitis 10/79 12.6 
Patent ductus arteriosus 6/79 7.5 
Depressed at birth 5/79 6.3 
Intra-ventricular hemorrhage 1/79 0.2 
 
 
Figure 13: Morbidity pattern 
Hyaline membrane disease was the commonest condition seen (41.7%) followed by sepsis, which 
affected one third of them (30.3%).  
NEC was seen in 12.5%, PDA in 7.5%, IVH in 0.2% and 6.3% were depressed at birth. 
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INTERVENTIONS DURING NICU STAY 
Table 14:  
Intervention Number (N= 79) Percentage (%) 
IV fluids 79/79 100 
Nasogastric feeds 79/79 100 
Umbilical venous line 64/79 81 
Umbilical arterial line 29/79 45.5 
CPAP 36/79 36.7 
Mechanical ventilation 9/79 11.3 
Percutaneous central line 3/79 3.7 
 
Figure 14:  Interventions during neonatal periods 
All babies were on IV fluids and Nasogastric feeds.  
Majority had umbilical venous lines inserted (81%), umbilical arterial lines in 36.7%.  
There were 9 babies (11.3%) requiring mechanical ventilation, 45.5% (36/79) needed CPAP, Inotropic 
support in 21.5% and 3.7% needed central venous lines. 
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NEPHROTOXIC DRUGS USED DURING NICU STAY 
 
Table 15:  
Drugs Number (N =79) Percentage (%) 
Aminoglycosides 71 89.8 
Ibuprofen 3 3.7 
Indomethacin 3 3.7 
 
 
 
Fig 15: Nephrotoxic drugs used in neonatal period 
Aminoglycosides were used in 89.8% of the babies while Ibuprofen and Indomethacin were used in 
3.7% each. 
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II. ASSESSMENT OF RENAL INJURY- LAB EVALUATION 
CREATININE LEVELS  
Serum creatinine samples were collected weekly starting at Day 3 and then  weekly  for 4 weeks and 
analysed. 
Table 16: Creatinine trend over 4 weeks 
Creatinine(mg/dl) N MIN MAX MEAN Std dev 
Week 1 78 0.33 1.31 0.73 0.21 
Week 2 64 0.29 1.22 0.58 0.2 
Week 3 54 0.1 1.65 0.44 0.21 
Week 4 46 0.13 1.19 0.35 0.19 
 
Figure 16: Trend of creatinine over 4 weeks 
The mean value of  creatinine  decreased from 0.73 mg/dl to 0.35mg/dl over 4 weeks. 
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COMPARISON OF  WEEKLY  CREATININE  
Table 17: Creatinine levels over the weeks 
Creatinine level 
   (mg/dl) 
Week 1 (n = 79) Week 2 (n = 64) Week 3 (n = 54) Week 4 (n = 46) 
  N Percentage%   N Percentage%   N Percentage %   N Percentage % 
   < 0.3 0 0 3 4.7 9 16.7 20 43.5 
   0.3 to 0.6 21 26.9 36 56.2 40 74.1 22 47.8 
  0.6 to 0.9 42 53.8 20 31.2 4 7.4 3 6.5 
   > 0.9 15 19.2 5 7.8 1 1.9 1 2.2 
 
 
 
 
 
Figure 17: In the first week, nearly half (53.8%) had creatinine in the range of 0.6 to 0.9 and one fifth 
(19.2) had creatinine levels more than 0.9.  
In week 2, highest numbers were in the 0.3 to 0.6 group (56.2%) followed by 0.6 to 0.9 group (31.2%). 
Only 5 had creatinine value of more than 0.9 
By week 3, three fourth had values between 0.3 to 0.6. By week 4, almost 90% had creatinine < 0.6 
Thus by week 4, from an initial 19.2 %, only 2.2 % had elevated creatinine values >0.9 mg/dl 
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CREATININE IN VENTILATED BABIES - (IMV AND CPAP) 
Table 18: Creatinine trend in IMV and CPAP groups 
CREATININE 
(mg/dL) 
IMV 
( n= 9) 
CPAP 
(n=36) 
Non Ventilation 
(n= 34) 
P value 
WEEK 1 0.8 0.7 0.7 0.401 
WEEK 2 0.6 0.6 0.6 0.944 
WEEK 3 0.7 0.4 0.4 0.03 
WEEK 4 0.3 0.4 0.3 0.573 
 
 
 
 
 
 
 
 
 
Figure 18:  Creatinine levels in  IMV and CPAP babies  
The Creatinine levels were almost similar in the IMV and CPAP group except in week 3 when the 
difference was statistically significant (p<0.05)   
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CREATININE IN ASPHYXIATED BABIES 
Table 19: 
CREATININE 
(mg/dl) 
ASPHYXIA 
(n = 6) 
NON ASPHYXIA 
(n=73) 
P value 
WEEK 1 0.75 0.73 0.778 
WEEK 2 0.53 0.59 0.488 
WEEK 3 0.43 0.44 0.856 
WEEK 4 0.33 0.35 0.784 
 
Figure 19: 
The values of Creatinine were almost in the same range in the asphyxiated babies and the non 
asphyxiated babies.  
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CREATININE and NSAID DRUGS 
Table 20:  NSAID drugs and creatinine 
CREATININE 
(mg/dl) 
NSAID drugs 
(n=7) 
No NSAID drugs 
(n=72) 
P value 
WEEK 1 O.72 0.73 0.884 
WEEK 2 0.69 0.57 0.149 
WEEK 3 0.61 0.42 0.048 
WEEK 4 0.34 0.49 0.102 
 
Figure 20: NSAID drugs used were Indomethacin and Ibuprofen.  
Weekly creatinine remained high in all weeks but was statistically significant in week 3 (p= 0.048) 
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CREATININE AND UMBILICAL LINES 
Table 21: 
CREATININE 
   (mg/dl) 
UA + UV  lines 
(n=29) 
No lines 
( n= 50) 
P value 
WEEK 1 0.78 0.71 0.884 
WEEK 2 0.6 0.56 0.149 
WEEK 3 0.51 0.41 0.048 
WEEK 4 0.39 0.33 0.102 
 
 
Figure 21:  
Creatinine levels  were significantly higher in those with umbilical lines in week 3 (p=0.048) 
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CREATININE AND INOTROPES 
Table 22 
CREATININE (mg/dL) Inotropes No Inotropes P value 
WEEK 1 0.8241 0.7126 0.53 
WEEK 2 0.6264 0.5714 0.388 
WEEK 3 0.6429 0.4177 0.008 
WEEK 4 0.3425 0.3581 0.879 
 
 
  Figure22:                                                                  
Creatinine values were higher in the inotrope group,  but it was significantly higher in week 3 (p<0.05) 
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 III. COMPARISON OF NGAL AND CREATININE 
 
As part of a pilot study Urinary NGAL was studied to assess its usefulness as an early biomarker for 
AKI in preterm babies. Its ability to predict UTI before a rise in creatinine occurs was studied. 
 
Weekly urine samples from a total of 31/79 babies were processed and the data was analysed. 
 
NGAL values were compared with various risk factors for AKI as well as with concomitant serum 
creatinine values in the same patients. 
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URINARY NGAL LEVELS   
Urine for NGAL was collected and analysed in 31 babies once a week till discharge (4weeks) 
Table 23: Mean values of NGAL 
NGAL (ng/ml) N MIN MAX MEAN Std dev 
 Week 1 29 14.38 979.1 260.51 264.09 
Week 2 31 4.88 850.2 184.66 228.12 
 Week 3 32 0 448.85 83.68 93.91 
 Week 4 17 0 105.08 36.33 35.19 
 
Figure 23: Mean value of NGAL over the weeks 
The mean value of NGAL showed a decreasing trend from 260.5 to 36.3 over 4 weeks. 
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COMPARISON OF WEEKLY NGAL VALUES  
Table 24:  
NGAL level 
 ( ng/ml) 
Week 1 (n = 31) Week 2 (n = 31) Week 3 (n= 31) Week 4 (n = 17) 
 N Percentage %   N Percentage%  N Percentage %  N Percentage % 
< 250 18 58.1 24 77.4 30   96.4 17 100 
250 – 500 9 29 4 12.9 1    3.1 0 0 
> 500 4 12.9 3 9.7 0     0 0 0 
 
Figure 24: 
In the first week, there were 58.1% with NGAL < 250, but 12.9% had values more than 500. 
By week 2, nearly 80% had values < 250. By week 3 and 4, almost all (96.4 and 100%) had values < 
250. 
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NGAL VS GESTATIONAL AGE 
Table 25:  
NGAL  (n=31) WEEK 1 WEEK 2 WEEK 3 WEEK 4 
Pearson correlation 0.77 0.71 0.135 0..141 
P value 0.079 0.704 0.462 0.015 
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Figure 25: 
Weekly NGAL values were plotted against gestational age.  
Gestational age and NGAL showed an inverse relationship. However this was not  statistically 
significant. (p=>0.05) except in week 4. 
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NGAL VERSUS BIRTH-WEIGHT 
Table 26: 
NGAL (ng/ml) Week 1 Week 2 Week 3 Week 4 
Pearson correlation -0.112 -0.066 -0.237 -0.446 
P value 0.561 0.726 0.192 0.073 
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Figure 26: 
Weekly NGAL values showed an inverse relation with birth-weight. With increasing birth weight, 
NGAL values decreased. However this  was not statistically  significant. 
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COMPARISON OF NGAL WITH CREATININE 
NGAL values for different risk factors were assessed and compared with concomitant creatinine values 
in the same babies.  
NGAL IN VENTILATED BABIES: MECHANICAL VENTILATION AND CPAP 
Table 27:  
NGAL (ng/ml) 
   n=31 
IMV 
(n= 2) 
CPAP 
(n=13) 
No Ventilation 
(n=16) 
P value  
WEEK 1 599 230 234 0.147 
WEEK 2 830 196 93 0.000 
WEEK 3 99 83 80 0.982 
WEEK 4 0 31 33 0.923 
 
 
         
 
 
 
Figure 27:  
 
NGAL rise was higher in the IMV group compared to the CPAP group in most weeks. This difference 
was statistically significant (p<0.05) during week 2. 
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CREATININE : MECHANICAL VENTILATION AND CPAP 
Table 28:  
CREATININE (mg/dL)  
   n=31         
IMV 
(n= 2) 
CPAP 
(n=13) 
No Ventilation 
(n=16) 
P value  
WEEK 1 0.7050 0.7715 0.6488 0.231 
WEEK 2 0.6400 0.5331 0.5406 0.719 
WEEK 3 1.2250 0.3992 0.3838 0.000 
WEEK 4 0.37 0.44 0.3021 0.319 
 
 
 Figure:28                                                                                                                                                                                         
Creatinine rise was higher in the IMV group compared to the CPAP group in most weeks. This 
difference was statistically significant (p<0.05) during week 3. 
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NGAL IN ASPHYXIATED PRETERM BABIES 
Table 29: NGAL in asphyxia 
NGAL (ng/ml) 
 n=31 
ASPHYXIA 
n=6 
NO ASPHYXIA 
(n=25) 
P value 
WEEK 1 59.7 2.8 0.165 
WEEK 2 1.5 1.8 0.83 
WEEK 3 32 87 0.338 
WEEK 4 63 24 0.064 
 
 
Figure 29:                            
The NGAL values was compared with non asphyxiated babies. NGAL in weeks 1, 3 and 4 were higher 
but the difference  was not statistically significant.  
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CREATININE IN ASPHYXIATED PRETERM BABIES 
Table 30: Creatinine in asphyxia 
CREATININE 
(mg/dL) 
ASPHYXIA 
n=3 
NO ASPHYXIA 
(n=28) 
P value 
WEEK 1 0.84 0.6879 0.198 
WEEK 2 0.55 0.5428 0.938 
WEEK 3 0.4267 0.4464 0.904 
WEEK 4 0.3275 0.3754 0.711 
 
       
 
Figure 30: Creatinine in asphyxiated neonates was higher during the first week but this was not 
significant. (p>0.05)  
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NGAL AND UMBILICAL LINES  
Table 31 
NGAL 
ng/ml 
UA + UV 
(n=11) 
No lines 
(n=20) 
P value 
WEEK 1 281.82 237.58 0.641 
WEEK 2 279.91 127.01 0.212 
WEEK 3 98.88 71.94 0.482 
WEEK 4 42.12 22.55 0.64 
 
 
    
             
 
Figure 31: NGAL levels in this group were higher in the UA group but the difference was not  
statistically significant 
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CREATININE AND UMBILICAL LINES  
Table 32 
CREATININE 
  (mg/dL) 
UA + UV 
(n=11) 
No lines 
(n=20) 
P value 
WEEK 1 0.7091 0.6986 0.886 
WEEK 2 0.5809 0.5250 0.382 
WEEK 3 0.5482 0.3875 0.106 
WEEK 4 0.4620 0.3167 0.115 
 
                     
                                                                                                                                                                                                                                                                                           
Figure 33 : Creatinine values were higher in those with umbilical arterial and venous lines compared to 
with no arterial lines. This difference was not statistically significant (p value > 0.05) 
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NGAL AND NSAIDS 
Table 34: 
NGAL 
(ng/ml) 
NSAIDS 
(n=7) 
No NSAIDS 
(n = 72) 
P value 
WEEK 1 313.89 250 0.69 
WEEK 2 375 148.16 0.063 
WEEK 3 114.13 79.03 0.547 
WEEK 4 45.58 31.68 0.699 
 
 
 
 
 
 
 
 
Figure 34:Indomethacin and Ibuprofen were the NSAID - nephrotoxic drugs babies were exposed to.  
NGAL values were higher in those receiving NSAIDs  but the difference was not  significant. 
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CREATININE AND NSAIDS 
Table 35: 
CREATININE 
(mg/dL) 
NSAIDS 
(n=4) 
No NSAIDS 
(n = 27) 
P value 
WEEK 1 0.65 0.70 0.571 
WEEK 2 0.6775 0.5252 0.094 
WEEK 3 0.6975 0.4070 0.435 
WEEK 4 0.5375 0.3404 0.454 
 
 
Figure 35: Creatinine was found to persist at a higher value. However on comparing with unexposed 
babies, there was no significant difference (p>0.05) 
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NGAL and AMINOGLYCOSIDES 
Table 36 
NGAL (ng/ml) Aminoglycosides (n=30) No aminoglycosides (n=1) P value 
WEEK 1 264 69 0.295 
WEEK 2 170 188 0.914 
WEEK 3 83 20 0.531 
WEEK 4 32 83 0.158 
 
 
                                                          
Figure 36: Babies were exposed to aminoglycosides in the first week of life. Urinary NGAL showed a 
decreasing trend over the weeks. Compared to those with no exposure the level of NGAL was not 
significantly higher (p >0.05) 
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CREATININE AND AMINOGLYCOSIDES 
Table 37: 
CREATININE (mg/dL) Aminoglycosides 
(n=30) 
No aminoglycosides 
(n=1) 
P value 
WEEK 1 0.7074 0.54 0.402 
WEEK 2 0.5523 0.41 0.259 
WEEK 3 0.4393 0.60 0.558 
WEEK 4 0.3785 0.24 0.428 
 
                                     
                                                                                                                                                       
Figure 35: Babies were exposed to aminoglycosides in the first week of life. Serum showed a 
decreasing trend over the weeks. Compared to those with no exposure the level of creatininee was 
higher in the first week, however this was not significant (p >0.05) 
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IV. PREMATURITY AND AKI  
A total of 10 babies had AKI (12.6%). This group was studied further. 
Four babies with AKI had both creatinine and NGAL done and these values were compared 
CREATININE IN  THOSE WITH AKI 
Table 36 
Creatinine (mg/dl) Week 1 
 
Week 2 Week 3 Week 4 
Baby 1 0.7 0.37 0.2 0.8 
Baby 2 0.44 0.86 0.26 0.46 
Baby 3 0.76 0.71 1.65 0.37 
Baby 4 0.71 0.63 0.53 1.19 
 
 
Figure 36 
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NGAL IN BABIES WITH AKI 
Table 37: 
NGAL Week 1 Week 2 Week 3 Week 4 
Baby 1 427.5 - 90.1 - 
Baby 2 >1000 258.9 46.2 26.7 
Baby 3 238 850 >1000 - 
Baby 4 444.3 265 239 45.58 
 
 
     
Figure 37 
Comparison of creatinine and NGAL in those with AKI showed that the rise of NGAL was earlier than 
that of creatinine.  
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PROFILE OF AKI - GESTATIONAL AGE  
Table: 38 
Gestational age 28 weeks 29 weeks 30 weeks 31 weeks 32 weeks 
Number (n=10) 4/10 1/10 1/10 1/10 3/10 
Percentage % 40 10 10 10 30 
 
 
Figure 38: 
Of the ten babies with AKI, 40% were born at less than 28 weeks, 30% at 32 weeks and 10% each in 
29, 30 and 31 weeks. 
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BIRTHWEIGHT – AKI 
Table 39 
Birth-weight <1000 1001-1100 1101-1200 1201-1300 1301-1400 1401-1500 
Number (n=10) 1 2 3 1 1 2 
Percentage (%) 10 20 30 10 10 20 
 
 
Figure 39 
AKI was seen only in babies with birth-weight less than 1500 Gm.  
Of the ten, 30% were between 1101 to 1200 Gm, 20% each in 1001 to 1100 Gm and 1401 to 1500 Gm 
groups, 10% each in < 1000 Gm, 1201 to 1300 Gm and 1301 to 1400 gm. 
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MATERNAL FACTORS - AKI  
Table 40 
Factors Age <20 Age >30 Primigravida PIH Abnormal scan 
Number (n=10) 1 2 10 3 3 
Percentage% 10 20 100 30 30 
 
 
Figure 40 
All 10 mothers were primipara, 30% had PIH and abnormal doppler, 2 were more than 30 years (20%) 
of age and one teenage mother (10%) 
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MODE OF DELIVERY AND APGAR AT 5 MINUTES -  AKI 
Table 41 
Mode of delivery LSCS Normal Breech/forceps 
Number (n=10) 6 2 2 
Percentage% 60 20 20 
  
  
Figure 41: Caesarean section was mode of delivery in 60% and 20% each in normal and breech/low 
forceps category. 
 Five minute Apgar was more than 6 in 80% and less than 6 in 20% 
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RISK FACTORS IN THOSE WITH AKI 
Table 42: 
 Number (n=10) Percentage % 
Sepsis 10 100 
Hyaline membrane disease 3 30 
Patent ductus arteriosus 4 40 
Nephrotoxic drugs 3 30 
Mechanical ventilation 2 20 
CPAP 5 50 
 
 
Figure 42: Sepsis was suspected in all, one baby who had culture proven sepsis.  
The highest association with AKI was seen in sepsis (100%) followed by CPAP (50%) and PDA (40%) 
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RELATIVE RISK OF VARIOUS FACTORS IN AKI  
TABLE 43: 
FACTORS AKI NO AKI Relative risk 95%confidence interval 
PIH 3 28 0.664 0.185 to 2.375 
Abnormal scan 3 13 1.625 0.457 to 5.772 
Apgar < 6 2 6 2.188 0.558 to 8.574 
Asphyxia 0 8 -  
Oligo-anuria 2 0 9.652 4.995 to 18.547 
Hyaline membrane disease 3 30 0.597 0.167 to 2.141 
Patent ductus arteriosus 4 5 5.185 1.800 to 14.933 
NSAIDS 3 4 4.408 1.456 to 13.346 
Aminoglycosides 10 69 1.164 1.059 to 1.279 
Inotropes 2 15 1.097 0.256 to 4.693 
Mechanical ventilation 2 7 1.944 0.487 to 7.770 
CPAP  5 31 1.194 0.375 to 3.802 
Inotropes 2 15 0.912 0.213 to 3.901 
Death/DAMA 1 4 1.622 0.253 to 10.387 
 
The risk factors for AKI included Oligoanuria, PDA, Nephrotoxic drugs – NSAIDS and 
Aminoglycosides, low Apgar, Mechanical Ventilation, CPAP and abnormal Antenatal scan. 
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FINAL OUTCOME 
Table 44: Final outcome 
 Number (n = 79) Percentage 
Discharged 74 93.80% 
Death 3 3.70% 
DAMA 2 2.50% 
 
 
Figure 29: Final outcome 
There were 3 deaths (3.7%) and 2 were discharged against medical advice (2.5%).   
The remaining 93.6% were discharged well. 
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DISCUSSION 
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DISCUSSION 
Preterm babies are a vulnerable population and are exposed to various risk factors; predisposing them 
to multi-organ injury.   Due to the myriad of complications preterms are exposed to in the early weeks 
and multiple interventions with prolonged hospitalization, these babies are predisposed to acute kidney 
injury and its long term consequences. Factors predisposing to acute kidney injury are usually 
multifactorial, the most common among these being perinatal asphyxia and sepsis.  Both these factors 
are common in preterm babies. 
This study was conducted in Neonatal intensive care unit as collaboration between Departments of 
Neonatology and Pediatrics unit II during the period - May2014 and August 2014.  During the study 
period, babies born at less than 32 weeks of gestational age were recruited for the study.  Those babies 
with abnormal antenatal renal scans, major systemic congenital anomalies and chromosomal anomalies 
were excluded.  
During the study period, there were 4823 live births. Average live births per month were 1200. 
Numbers of preterm deliveries were 789 (less than 37 weeks) (16.36%). There were 80 deliveries < 
32+6 weeks gestation (10.14%).There were 79 babies that fulfilled the inclusion criteria of the study 
and were recruited. On an average, there were 23 babies born at less than 32 weeks of gestational age 
for every 1000 live births. 
There were 57% males and 34% females ( M:F ratio: 1.3:1). Devarajan et al in their study on urinary 
NGAL in preterm babies also reported similar sex distribution of 60% males and 40% females (46).  
Parity of mothers delivering preterm babies was assessed. It was noted that prematurity of < 32+6 
weeks gestation was higher amongst the primipara (70.8%) than multipara (29.2%). An Indian study 
by Begum etal reported that amongst risk factors associated with preterm labour, primiparity was one 
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of the many predisposing factors. Other factors included elderly gravida, multi-fetal pregnancy, poor 
socio-economic status, lower educational status (10). 
 Teenage pregnancy is another known risk factor for prematurity. Nearly 62% were between 20 and 30 
years of age followed by those with maternal age > 30 years (25.3%). Those < 20 years of age was 
only 12.6%. This may be a reflection of a gradually increasing marriage age of Indian women. 
Education status of the Mothers was variable - from no education (29.1%) to post graduation (10.1%). 
Majority had attended primary school (35.4%).  
Multi-fetal pregnancies included 10 sets of twins and one set triplets.  Of the 10 sets of twins in the 
study, one of the twins was excluded in view of major congenital anomaly.  
Of the 79, antenatal ultrasonography was done only for 68 of them. Of the 68 scans, 31 were normal, 
22 showing multiple pregnancy and 15 were abnormal. Abnormalities included abnormal Doppler in 7, 
absent end diastolic flow in 3, IUGR in 1, minimal ascites in 1, placenta previa in 2 and breech in 1. 
There were 19 scans confirming twin pregnancy (ten sets of twins) and 3 scans with triplets. Two sets 
of twins had abnormal Doppler on antenatal ultrasonography. There was one set of triplet included in 
the study. An abnormal antenatal renal scan was an exclusion criterion for the study.  
Maternal risk factors included preterm pre-labour rupture of membranes (PPROM), chorioamnionitis; 
Pregnancy induced hypertension (PIH), Gestational Diabetes mellitus (GDM) and urinary tract 
infections.  In our study, PIH was the most common risk factor accounting for 39.2% followed by 
GDM accounting for 13.9%.  The numbers are almost identical to an American study in South 
Carolina that looked at association of PIH and hyaline membrane disease. Incidence of PIH was 42.6% 
and GDM was 12.5% in this study. (11) Drugs used in PIH included Magnesium sulphate, anti-
hypertensive drugs like alpha methyldopa, Nifidipine and Labetalol. Maternal risk factors’ 
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predisposing to neonatal sepsis like PPROM and chorioamnionitis was seen in 12.7% and 6.3% 
respectively.  
Institutional protocol advises antenatal steroids if there is onset of preterm labour less than 34 weeks of 
gestation. All mothers had received at least one dose of steroids in the antepartum period during labour 
as all of them were less than 32 weeks. Intra-partum antibiotics were given to 25 mothers (31.6%) with 
PPROM, chorioamnionitis and urinary tract infection. There were 2 (2.5%) with documented urinary 
tract infections.   
Mode of delivery included normal vaginal, Caesarean section, low forceps and breech.  Caesarean 
section was the mode of delivery in more than half of them (59.5%) followed by normal delivery 
(39.6%) and a small proportion (8%) of breech/low forceps delivery. Indication for Caesarean section 
included both maternal and neonatal factors – severe pre-eclampsia, failed induction, fetal distress and 
abnormal doppler.  The higher rate of Caesarean section many be due to the fact that that ours is a 
tertiary care center with more referrals for safer delivery in cases of complicated pregnancies.  
Apgar score (Appearance, Pulse, Grimace, Activity and Respiration) is an assessment score of 
neonates at 1 and 5 minutes of life. The 5-minute Apgar less than 7 is abnormal and 3 or less is 
suggestive of birth asphyxia. There were 71 babies with 5 minute Apgar more than 6 (91.1%) while 7 
(8.9%) had abnormal Apgar less than 6. Cord pH of less than 7.0 or first blood gas with pH of less than 
7.2 was taken as probable asphyxia. There were 3 (3.7%) babies who fulfilled the criteria. Stojanovic 
etal also reported metabolic acidosis to be more pronounced in the AKI babies during first 3 days of 
life, with lower serum pH. (21) 
Neonatal risk factors included those who needed resuscitation or intubation at birth and babies who 
were symptomatic at birth. There were 55 babies who were symptomatic at birth (69.6%). Of these, 17 
(21.5%) needed resuscitation and 15 (18.9%) were intubated. International Liaison committee on 
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resuscitation (ILCOR) guidelines mentions that atleast 10% of all deliveries need neonatal 
resuscitation.  The resuscitation rates were higher in our study as this included only preterm baby up to 
32 weeks of gestation as against the ILCOR guidelines who reported on all deliveries.  The 2010 
ILCOR guidelines also state that lower the gestational age, birth-weight and Caesarean sections are 
associated with higher risk of resuscitation at birth. (12) 
Resuscitation included bag and mask ventilation, use of neopuff and intubation. The indications for 
resuscitation included depressed at birth with low Apgar scores, secondary apnea and poor perfusion. 
Those with tachypnea and grunting were transported with neopuff. Neopuff provides positive 
inspiratory (PIP) and end expiratory pressure (PEEP) and functions like CPAP. Although 15 needed 
intubation, only 9 required long term mechanical ventilation. 
Symptoms varied in the 55 babies. Respiratory distress was the most common presentation (65.8%) 
followed by poor perfusion (11.3%). There were 2 babies who presented during the late neonatal 
period with apnea and seizures (2.5%). Abdominal distension (7.5%), temperature instability – 
hypothermia and hyperthermia (2.5%) and apnea (6.3%) were the other symptoms. Urine output was 
monitored using urine collecting bags or weighing cotton pads. Oliguria, defined as urine output less 
than 0.5 ml/kg/hour, was seen in 2 babies and anuria was later noted in one of these two.  Cataldi etal 
found Hyaline membrane disease as a common cause of pre-renal failure. However it was the severity 
of the disease, rather than just the presence of the disease that increases incidence of AKI (34). 
Interventions during the NICU stay included intravenous lines – both peripheral and central lines, 
umbilical venous and arterial lines, mechanical ventilation, CPAP, intravenous fluids, nasogastric 
feeds. All 79 babies were on intravenous fluids, nasogastric feeds and had peripheral intravenous 
catheters. Umbilical venous lines were inserted in 64 babies (81%) and umbilical arterial lines in 29 
babies (36.7%). There were no complications associated with umbilical lines like infection, renal vein 
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thrombosis, displacement of the lines or line related infections. Central venous line was needed in 3 
babies (3.7%) and there were no complications.  
Non-invasive ventilation in the form of CPAP was used for 36 babies (45.5%). There were no 
complications like pneumothorax. However, three of them who failed to improve on CPAP went on to 
mechanical ventilation.  There were a total of 9 babies who needed mechanical ventilation. Five of 
them were given surfactant therapy. There were no complications like pneumothorax or ventilator 
associated pneumonia. One of them had culture proven sepsis – Non-fermenting gram negative bacilli 
requiring prolonged ventilation.  
The complications adding to morbidity was multi-systemic. These included Hyaline membrane disease 
(41.7%), probable sepsis (30.3%), probable necrotizing enterocolitis (12.6%), Patent ductus arteriosus 
(7.5%). Only one case of grade 3 intra-ventricular hemorrhage was seen who went on to develop 
hydrocephalus. Of the 33 with hyaline membrane disease, 7 were ventilated by conventional 
mechanical ventilation and 26 needed CPAP support.  
There were 24 babies who were at risk of sepsis. There were only three culture proven sepsis – one 
with non-fermenting gram negative sepsis, one with gram negative sepsis and the third with 
Enterococcal sepsis. Broad-spectrum antibiotics (Penicillin/Ampicillin and Gentamicin) started for 
those who were at risk of sepsis according to WHO criteria. (13) Other antibiotics used included 
Ciprofloxacin, Amikacin, Cefoperazone sulbactum, Netilmycin, Meropenem, Vancomycin and 
Colistin. Inotropes were used in 17 babies (21.5%) while blood transfusion was given to 2 babies. 
There were 2 babies with myocardial dysfunction – one requiring mechanical ventilation while the 
other was conservatively managed with fluid restriction, diuretics and inotropic support.  
Patent ductus arteriosus was diagnosed in 7 babies, 3 were given oral Ibuprofen and 3 were given 
Indomethacin. There was oliguria in one baby post Indomethacin. This was managed conservatively. 
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A total of 10 babies were diagnosed with necrotizing enterocolitis – 7 had stage 1 while 3 babies had 
stage 2 NEC. None of them had bowel perforation or needed surgical intervention. Conservative 
management with antibiotics, IV fluids, total parenteral nutrition and resting the gut by keeping them 
nil by mouth. There was no mortality seen in this group. 
Three babies died who were ventilated – one had severe hyaline membrane disease and was given 
surfactant and inotropes but died on day 4 of life. One baby had very high bilirubin due to gram-
negative sepsis, developed bilirubin encephalopathy and died despite supportive measures and 
antibiotics, died of late onset gram negative sepsis. The third died due to probable sepsis on day 9 of 
life.  The mortality rate was 3.7%. Two babies were discharged against medical advice. The corrected 
survival rate was 93.6% (74 of 79 survived). 
DIAGNOSIS OF AKI  
Blood and urine samples were collected weekly for the first 4 weeks of life during the stay in NICU to 
assess the risk of Acute Kidney injury in these babies. The first samples for serum creatinine and 
urinary NGAL were collected after 72 hours of life. Serum creatinine was processed by standard 
methods in Clinical Biochemistry department. Urinary NGAL samples were collected and stored at 
sub-zero temperatures. These were processed by rapid ELISA using KIT 037 by BioPorto diagnostics. 
  Serum creatinine was collected and processed for all 79 babies. Urinary NGAL was processed only 
for 31 babies as a pilot study to look at usefulness of NGAL as a biomarker of AKI in preterm babies.  
 Creatinine and NGAL values were looked at and correlated with various risk factors.  
The mean value of Creatinine values decreased from 0.73mg/dl to 0.35mg/dl during week 1 to 4. In 
the first week, nearly half (53.8%) had creatinine in the range of 0.6mg/dl to 0.9mg/dl and one fifth 
(19.2) had creatinine levels more than 0.9mg/dl. In week 2, highest numbers were in the 0.3mg/dl to 
0.6mg/dl  group (56.2%) followed by 0.6mg/dl to 0.9mg/dl group (31.2%). Only 5 had creatinine value 
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of more than 0.9mg/dl. By week 3, three fourth had values between 0.3mg/dl to 0.6mg/dl.  By week 4, 
almost 90% had creatinine less than 0.6mg/dl. Thus by week 4, from an initial 19.2 %, only 2.2 % had 
elevated creatinine values. 
The Creatinine levels were compared with various risk factors. It was found to be elevated in those 
undergoing mechanical ventilation- both IMV and CPAP. It was found to be almost similar in the IMV 
and CPAP groups except in week 3 when the difference was statistically significant (p<0.05). The 
values of Creatinine were almost in the same range in the asphyxiated babies and the non asphyxiated 
babies and there was no statistical difference between these values. As there were only 6 babies who 
suffered asphyxia, this association needs to be studied further as asphyxia is a known risk factor for 
AKI and other morbidity.  
Use of NSAIDS is also considered a risk factor for AKI, especially in preterm babies as it is used in the 
management of PDA. Weekly creatinine values remained high in all weeks but was statistically 
significant only in week 3 (p= 0.048). This may correspond to its usage as PDA is one of the known 
later complications appearing in week 2 or 3. Creatinine levels were significantly higher in those with 
umbilical lines in week 3 (p=0.048). Creatinine values were also higher in  those receiving inotropes,  
but it was significantly higher in week 3 (p<0.05). The late rise of serum creatinine in all these cases 
after the initial fall could represent either a delayed detection of AKI or could represent the occurrence 
of AKI as a cumulative effect of several co-morbid factors. 
NGAL estimation in 31 babies showed a decreasing trend from 260.5ng/ml  to 36.3ng/ml during week 
1 to 4. In the first week, there were 58.1% with NGAL less than 250ng/ml, but 12.9% had values more 
than 500ng/ml. By week 2, nearly 80% had values less than 250ng/ml. By week 3 and 4, almost all 
(96.4 and 100%) had values less than 250ng/ml. The change in creatinine was in the range of decimal 
point while that of NGAL change was in hundreds.  NGAL thus may reflect changes in renal function 
more accurately than serum creatinine.  
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NGAL levels was compared with gestational age and birth weight over the 4 weeks. It was found that 
with increasing gestational age, NGAL showed a decreasing trend.  However this was not found to be 
statistically significant. (p= >0.05) except in week 4. Similarly NGAL values for different birth-weight  
showed that NGAL values were higher in those with lower in birth-weight. This was not statistically 
singnificant (p value >0.05). Devarajan etal also reported that NGAL values were inversely 
proportional to gestational age and birth-weight, but the change was statistically significant (p<0.01). 
Twenty normal preterm babies were grouped based on birth-weight and urinary NGAL was monitored 
daily for the first 14 days. However further studies are required to establish normal range of NGAL in 
this group of patients. (31) 
NGAL and creatinine in ventilated babies was compared over the 4 week study period. NGAL rise 
was significant in the IMV group in week 2 (p<0.05). However, in the CPAP group a similar rise 
was not noted in any of the weeks. When creatinine levels were looked at, the IMV group showed a 
statistically significant (p<0.05) increase in Creatinine at week 3. This could be a reflection of the 
fact that the NGAL rise preceded the rise in creatinine by a week.  
Asphyxia was defined as cord pH less than 7.0 or blood gas pH less than 7.2 during the first 24 hours 
of life. There were 3 babies with suspected asphyxia.  The NGAL values of asphyxiated babies was 
compared with babies with no asphyxia; and it was found that  NGAL in weeks 1, 3 and 4 were higher 
but this was not statistically significant. Similarly, serum creatinine values were higher in babies with 
asphyxia in the initial weeks compared to later weeks- but the difference was not statistically 
significant. 
Nephrotoxic drugs included mainly NSAIDS and aminoglycosides. NSAIDS used included 
Indomethacin and Ibuprofen. Both NGAL values and creatinine persisted at a higher level in these 
babies compared to babies not exposed to NSAIDS. The level of rise of  NGAL was much higher than 
rise in creatinine but the  difference was not statistically significance (p>0.05). 
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Those with umbilical arterial and venous lines were compared with those with no lines. Both NGAL 
and Serum creatinine showed a decreasing trend and there was no significant difference between the 
two. 
ACUTE KIDNEY INJURY IN THE STUDY 
Acute kidney injury was defined as an absolute value of more than 1.3 mg/dL or a rise of more than 
50% of the previous value.  Different studies have used different cut-off values of creatinine. Cataldi 
etal reported AKI in preterm babies in a case control study, where creatinine of more than 1.3 mg/dL 
was used to define AKI. (34) Mortazavi etal looked at both term and preterm babies, wherein 
creatinine of more than 1.5 mg/dL was used to define AKI (1). The most recent study from Serbia in 
2014 by Stojanovic etal defined AKI as rise in creatinine more than 0.3 mg/dL compared to the 
previous value. (22) 
In our study, the incidence of AKI was 12.6% (10/79). Of these, 2 babies had high absolute value of 
creatinine - more than 1.3 mg/dL. One of these also showed a rise of more than 50% compared to the 
previous value. There were 8 other babies who showed rise of more than 50% compared to the 
previous creatinine value. 
According to the AKIN criteria (23), 3 babies belonged to stage I while 6 were stage II. One was an 
absolute value of creatinine > 1.3 mg/dL and therefore not defined by AKIN criteria.  
 Four of the ten babies had concomitant NGAL levels done. The NGAL levels were high and 
corresponded to the creatinine levels. In all of them, the NGAL levels were found to rise before the 
rise creatinine level.  
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Of the babies with AKI, four were females and six were males. There was a male preponderance in the 
entire study group and in those with AKI. The male to female ratio was 1.5:1. Mortazavi etal also 
found a male preponderance but male to female ratio was 2:1. (1) 
All ten babies had birth-weight less than 1500 gm.  Of these, one was  less than 1000 gm, two each 
weighing between 1001 to 1100 and 1401 to 1500, 3 between 1101 to 1200 and one each between 
1201 to 1300 and 1301 to 1400.  Cataldi etal also reported a higher incidence rate (79%) in babies less 
than 1500 Gm. (34) However, this study included all preterm babies less than 37 weeks whereas our 
inclusion criteria was only up to 32+6 weeks of gestational age. A greater sample size of AKI may 
help to look at this association better. 
Among the ten with AKI, 40% were less than 28 weeks of gestational age. This was a finding also 
reported by Stojanovic etal and Cataldi etal (22, 34). This may be due to higher incidence of co-
morbidities like sepsis, perinatal asphyxia, hyaline membrane disease, patent ductus arteriosus, need 
for mechanical ventilation and nephrotoxic drugs. 
Maternal risk factor like pregnancy-induced hypertension was present in three of them (30%). 
Abnormal Doppler was seen in 3 of them (30%). Only one baby was depressed at birth (10%).  
Stojanovic etal also found that maternal complications like PIH, Diabetes, chorioamnionitis and 
antibiotics were common in preterm babies and could contribute to the risk of renal failure. However 
in their study these factors were not found affect renal function in the neonate. (22) 
Hyaline membrane disease was seen in 4/10 of children with AKI. All of them required non-invasive 
ventilation in the form of CPAP.  Cataldi etal reported a higher incidence of Hyaline membrane 
disease (89%). This   high incidence is probably because their Neonatal ICU provides care to preterm 
babies born at less than 25 weeks (34). Our NICU has a protocol to admit babies only 27 weeks and 
beyond, keeping in mind the problems and morbidity associated with such extreme prematurity. 
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Cataldi et al also reported that Hyaline membrane disease increases pre-renal failure by affecting renal 
plasma flow and reducing the glomerular filtration rate 
Three babies had ECHO proven hemodynamically significant Patent ductus arteriosus; two of them 
were treated with IV Indomethacin and one with oral Ibuprofen. One of them developed oliguria 
following Indomethacin and was managed conservatively with IV fluids.  The one following Ibuprofen 
had elevated creatinine at the end of 4 weeks and was otherwise asymptomatic (normal urine output 
and gaining weight) while the other two had normal creatinine by the 4th week. Though the number is 
small, Nephrotoxic drugs like Indomethacin and Ibuprofen were associated with development of AKI 
in our study. Stojanovic etal (22) and Cataldi etal found similar incidence of PDA (40%) in their 
studies. Cataldi found that Ibuprofen was one of the factors predisposing to AKI. (34) On follow up, 
the creatinine normalized in these babies exposed to nephrotoxic drugs. Therefore the renal 
dysfunction was only transient. This needs further study with a larger cohort. 
The risk factors for developing AKI were assessed by comparing the AKI group with the non AKI 
group. The creatinine and NGAL for these was also compared in the two groups and found that the rise 
of NGAL was earlier than that of creatinine. We noted that the rise in creatinine by decimal points (0.2 
to 0.4 mg/dL) may be overlooked compared to NGAL levels which rises in hundreds. This may make 
it a more useful as a biomarker of in the early detection of AKI. 
Sepsis was a factor common to all ten babies while none with asphyxia were in the AKI group. CPAP 
(50%), Patent ductus arteriosus(40%), drugs like NSAIDS (30%), hyaline membrane disease (30%), 
mechanical ventilation (20%) were the other factors.  
In our study, the Relative risk of developing AKI was found to be associated with factors like Oligo-
anuria, PDA, nephrotoxic drugs, low Apgar, Mechanical Ventilation, CPAP and abnormal Antenatal 
scan. Mortazavi etal found asphyxia and sepsis to increase the risk of AKI. Cataldi etal reported low 
Apgar, PDA and use of nephrotoxic drugs to increase AKI incidence. The most recent study by 
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Stojanovic etal showed low Apgar, metabolic acidosis, NEC, intra-ventricular hemorrhage, use of 
Vancomycin and Dopamine as independent factors predisposing to AKI. 
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                                                               SUMMARY 
•  Descriptive study looking at incidence of Acute renal failure in preterm babies 
•  This study was conducted in Neonatal intensive care unit as collaboration between Departments 
of Neonatology and Pediatrics unit II during the period  May 2014 and August 2014.  
•  During the study period, babies born at less than 32 weeks of gestational age were recruited for 
the study.   
•  Those babies with abnormal antenatal renal scans, major systemic congenital anomalies and 
chromosomal anomalies were excluded.  
• Sample size was calculated based on incidence of renal failure. Incidence of renal failure 
worldwide ranges from 3.4 to 24% as mentioned in an Iranian study. Assuming that incidence 
of renal failure in our population is 10% with a precision of 6% and confidence interval of 
95%, sample size was calculated to be 96.  
•  There were a total of 4823 live births during this period.  Of the total 789 preterm deliveries, 80 
were preterm deliveries < 32 weeks gestation (10.14%). Of this group, a total of 79 were 
recruited in the study. One baby was excluded in view of major congenital anomaly. 
• Blood sampling for serum creatinine and urine for NGAL was collected once a week.Serum 
creatinine was processed in Clinical biochemistry lab of CMC Vellore using standard methods. 
• Urine NGAL was processed for 31 babies as part of a pilot study to look if it was useful in 
detecting acute kidney injury in this population.  Urine NGAL was processed using a rapid 
ELISA kit (kit 037). 
• Serum creatinine more than 1.3 mg/dL or more than 50% rise of creatinine compared to 
previous value was used to define AKI. 
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•  Weekly monitoring of risk factors, interventions, drugs were noted.  First sample of Serum 
creatinine and urine for NGAL were collected after 72 hours of age. 
•  The data was statistically analysed using SPSS software, version  
• A total of 79 babies were recruited. Of these, three died (one within 3 days of life and two were 
late neonatal deaths). There were 3 deaths (3.7%) and 2 were discharged against medical advice 
(2.5%).  The remaining 93.6% were discharged well. 
• There were 12 babies (15.1%) between 27 to 28 weeks, 26 (32.9%) between 29 to 30 weeks and 
between 31 to 32 weeks there were 41 (51.8%). 
• More than half the babies (56.1%) had birth weight between 1001 to 1500 Gm, while a third 
weighed between 1500 and 2000 Gm. (31.6%). 
• There were 45 males (57%) and 34 females (43%).  The male: female ratio was 1.3: 1. 
• There were 63.3%% mothers  who were between 20 and 30 years , followed by 27.9% more than 
30 years and 8.8% less than 20 years. 
• 29.1% mothers were uneducated, 35.4% had primary school education, 21.5% mothers who were 
graduates and only 10.1% postgraduates 
• Of the total, 69/79 babies had antenatal scans done. Normal scans were noted in 44.9% while 
17.3% were abnormal. Remaining confirmed multiple preganacies. Abnormal scans included 
abnormal Doppler and IUGR, while one baby had fetal ascites. 
• Most common mode of delivery was LSCS in 47 (59.5%) followed by normal delivery in 25 
(31.6%) and Breech/instrumental in 7 (8.8%) 
• Majority were primipara - 56 (70.8%); while 23 (29.2%) were multigravida  
• PIH was the commonest morbidity seen in the Mothers (39.2%) followed by PPROM (22.7%). 
Other risk factors included GDM (32.9%), UTI (2.5%) and chorioamnionitis (6.3%). 
• There were 72 babies (91.1%) with Apgar score more than 6 and 7 with Apgar less than 6 (8.8%) 
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• There were 55 babies (69.6%) who were symptomatic at birth. Resuscitation was needed in 
21.5% and intubation in 18.9% 
• Respiratory distress was the most common symptom (65.8%) followed by poor perfusion 
(11.3%). Others included abdominal distension (7.5%), apnea (6.3%) temperature instability, 
(5%), seizures (2.5%), hypoglycemia (0.2%) and decreased urine output (2.5%) 
• Hyaline membrane disease was the commonest condition seen (41.7%) followed by sepsis, 
which affected one third of them (30.3%).  NEC was seen in 12.5%, PDA in 7.5%, IVH in 
0.2% and 6.3% were depressed at birth. 
• All babies were on IV fluids and Nasogastric feeds. Majority had umbilical venous lines inserted 
(81%), umbilical arterial lines in 36.7%. There were 9 babies (11.3%) requiring mechanical 
ventilation, 45.5% needed CPAP, Inotropic support in 21.5% and 3.7% needed central venous 
lines. 
• Aminoglycosides were used in 89.8% of the babies while Ibuprofen and Indomethacin were used 
in 3.7% each. 
• The mean value of weekly creatinine values decreased from 0.73 to 0.35mg/dl from week 1 to 
week 4. 
• In the first week, one fifth (19.2%) had creatinine levels more than 0.9mg/dl but by week 4this 
had decreased to 2.2%.. 
• Creatinine values almost similar in the IMV and CPAP groups except in week 3 when the 
difference was statistically significant (p<0.05). 
• The values of Creatinine showed no statistical difference in the asphyxiated and non 
asphyxiated group. 
• Weekly creatinine remained high in all weeks in babies receiving NSAIDS  but was statistically 
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significant in only in week 3 (p= 0.048). 
• Creatinine levels were significantly higher in those with umbilical lines in week 3 (p=0.048). 
• Creatinine values were higher in  those receiving inotropes, but it was significantly higher in 
week 3 (p<0.05). 
• The significant rise of Serum creatinine in the 3rd week could represent either a delayed 
detection of AKI or could represent the occurrence of AKI as a cumulative effect of several co-
morbid factors. 
• NGAL values were calculated in 31 babies and compared with the concomitant serum 
creatinine values in 31 babies. 
• The mean value of NGAL over 4 weeks showed a decreasing trend from 260.5 to 36.3ng/ml. 
• In the first week, 12.9% had NGALvalues more than 500ng/ml, but by week 4 all values were 
< 250ng/ml. 
• NGAL was inversely proportional to gestational age but not this was not statistically 
significant. (p=>0.05) 
• Weekly NGAL values showed an inverse relationship to birth weight, but this  was not 
statistically significant. 
• NGAL rise  was statistically significant in the IMV group in week 2 (p<0.05) compared to  
CPAP. Creatinine rise was statistically significant (p<0.05) in the IMV group compared to the 
CPAP group but in week 3.  
• NGAL in weeks 1, 3 and 4 were higher but  not statistically significant in the 3 babies with 
suspected asphyxia. Serum creatinine also did not show a rise. 
• NGAL values were higher than creatinine  in those receiving NSAIDS and aminoglycosides. 
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(Indomethacin, Ibuprofen and Gentamicin) but the difference was not significant. (p >0.05) 
• There was no difference in the NGAL and Creatinine levels in those with umbilical arterial  
lines. 
• Comparison of creatinine and NGAL in those with AKI showed that the rise of NGAL was 
earlier than that of creatinine.  
• The incidence of AKI was 12.6% (10/79). 
• Of the ten babies with AKI, 40% were born at less than 28 weeks, 30% at 32 weeks and 10% 
each in 29, 30 and 31 weeks. 
• AKI was seen only in babies with birth-weight less than 1500 Gm. Of the ten, 30% were 
between 1101 to 1200 Gm, 20% each in 1001 to 1100 Gm and 1401 to 1500 Gm groups, 10% 
each in < 1000 Gm, 1201 to 1300 Gm and 1301 to 1400 gm. 
• All 10 mothers were primipara, 30% had PIH and abnormal Doppler, 2 were more than 30 
years (20%)of age and one teenage mother (10%) 
• Caesarean section was mode of delivery in 60% and 20% each in normal and breech/low 
forceps category. Five minute Apgar was more than 6 in 80% and less than 6 in 20% 
• Sepsis was seen all of 10 babies  with one having culture proven sepsis. Half (5/10) needed 
CPAP while 2/10 were ventilated. Hyaline membrane disease was present in 3/10 and PDA in 
4/10. NSAIDs were used in 3/10 of those with AKI. 
•  The relative risk of developing AKI was highest with factors like Oligo-anuria, PDA, 
nephrotoxic drugs, low Apgar, Mechanical Ventilation, CPAP and abnormal Antenatal scan. 
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CONCLUSIONS: 
 
• The incidence of AKI in preterms less than 32 weeks of gestational age was found to be 12.6%. 
• There was a higher incidence in babies born at 28 weeks or less babies less than 1500 gm at 
birth. 
•   The risk factors for AKI included Oliguria, PDA, Nephrotoxic drugs, low Apgar, Mechanical 
Ventilation, CPAP and abnormal Antenatal scan. 
•     Serum creatinine was significantly higher in babies receiving mechanical ventilation, NSAIDS 
and inotropes. 
•     The rate of rise of NGAL was earlier and the absolute number was also higher than creatinine 
(decimal points in creatinine while   hundreds in NGAL). 
•  NGAL rise was seen in AKI group as well as babies with risk factors like NSAIDS, mechanical 
ventilation and asphyxia. NGAL levels were inversely proportionate to gestational age and 
birth-weight. 
• Analysis of NGAL values in all 79 babies in the study group may help to more clearly establish 
its usefulness as a biomarker. 
•   A study with larger sample size is required in preterm babies to establish reference values for 
NGAL and its role as an early biomarker of AKI. It also needs to be studied in greater detail in 
term babies also who may exposed to various other morbidities including hypoxic ischemic 
injury.  
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LIMITATIONS 
 
 
• As this was a pilot study only representative urine samples could be analysed for NGAL. 
• The follow up at 3 and 6 months could not be completed. 
 
 
 
RECOMMENDATIONS: 
• Follow up of preterm babies who had AKI or risk factors AKI at 6 months to look at growth, 
serum creatinine, urinary NGAL and renal size. 
• Larger study with bigger sample size to study the risk factors of AKI and prematurity.  
• NGAL as a maker of AKI in preterm and term neonates needs to be studied further. 
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INFORMED CONSENT 
 
Informed Consent form to participate in a research study  
Study Title: 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
 
   
        
NARF study  
 
(Subject) 
(i) I confirm that I have read and understood the information sheet dated _________ for the above 
study and have had the opportunity to ask questions. [     ] 
(ii) I understand that my baby's participation in the study is with my consent and that I am 
free to withdraw him/her at any time, without giving any reason, without his/her medical care or 
legal rights being affected. [ ] 
 (iii) I understand that the researcher wants to collect blood and urine for this study. I give consent for 
the collections of such specimens [   ] 
(iv) I understand that, instead of throwing away the remaining specimen, the researcher wants to 
store it and use it for future research projects. I have no objection to the specimen (including urine, 
blood, blood cells, plasma and serum, collected for this study be used for other research projects [   ] 
(v) I understand that the researcher or anyone authorized by the authorities will not need my 
permission to look at my child’s health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I decide to withdraw him/her from the trial. I 
agree to this access. However, I understand that his/her identity will not be revealed in any 
information released to third parties or published. [   ] 
(vi) I agree not to restrict the use of any data or results that arise from this study provided such a use 
is only for scientific purpose(s) [   ] 
(vii) I give consent for my baby to take part in the above study. [   ] 
 
Signature (or Thumb impression) of Legally Acceptable Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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INFORMATION SHEET 
 
 
Preterm babies are a vulnerable population and at risk for various complications. Renal injury is one of 
them. As these babies have immature kidneys, they are more prone to kidney damage. Some of the 
other problems which occur in preterm babies like delayed cry at birth, need for oxygen, breathing 
difficulty, feed intolerance, etc may also adversely affect the kidney. Tests available for detecting 
kidney injury are not as useful as in older children.  A new test will be done on your baby’s urine to see 
if it is useful in detecting kidney injury before your baby becomes symptomatic. We also want to find 
out how common is kidney injury in preterm babies and we are often not sure whether the damage 
completely resolves or not. We need to monitor your child’s renal function over the next few months 
till we are sure it has resolved. 
 
You are requested to volunteer and enroll your baby for the NARF study. 
 
Once enrolled in the study, we will closely follow your baby’s progress in the hospital, involves taking 
weekly special urine and routine blood tests. About 2 ml blood will be withdrawn per week. Blood 
collection may lead to minimal discomfort to the baby and is unlikely to lead to any complications.  
 
This study involves follow up of kidney function during the first 4 weeks of life and once your baby 
gets discharged, he/she will be followed up till 6 months of age. The two follow up visits at 3 months 
and 6 months will be during routine check up in High risk infant clinic. During these visits, a single 
blood and urine test for kidney function will be done. At 6 months visits, in addition to these tests, an 
ultrasound scan is also done.  
 
Preterm babies routinely require blood and urine tests. Along with these tests, we’ll do an ultrasound 
scan. The urine test will be done free of cost. The blood test and ultrasound scan are routinely done 
tests and the cost will need to be borne by the parents. 
 
The data collected and the bloods/urine tests done may be used for future studies which may help us 
gain further knowledge of renal failure in children. 
 
At any point, you may withdraw your baby from the study. This will not compromise care during 
his/her stay in the hospital or in the future. He/she will continue to receive the best standard of care. 
 
The study does not involve free hospital care or free medicines. 
 
Your baby's identity is confidential and at no point will be disclosed. 
 
In case you have any queries, please contact me at 0416-2283348. 
 
Dr Indira Agarwal /Nithya J P 
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QUESTIONS 
 
1. What is this study about? 
 
             There is no information available on how common is kidney failure in preterm babies. It is 
believed to be under diagnosed as these children are not routinely followed up. Because they are a 
vulnerable population, this study aims to look at how common is kidney damage in preterm babies. We 
also hope to identify the risk factors for renal damage in this group so that we can suggest appropriate 
guidelines for follow up. 
 
2. What kind of test will be done? 
Your baby will get the standard care of treatment. This includes routine blood tests done as per 
protocol and additional special urine test will be collected on a weekly basis and stored for few 
months. Once analyzed, we will try to assess its usefulness in predicting kidney damage. 
 
3. Can these tests harm my baby?  
No. Blood tests may lead to discomfort but no complications involved. The volume of blood collected 
is also minimal. Urine collection is a non-invasive test and will not cause any difficulty in collection. 
 
4. Are these standard tests ?  
Yes, one blood test called creatinine is used as marker for kidney damage in all age groups and is being 
routinely tested all the time. NGAL tested in the urine, is a new marker, which has been tested in other 
centers. The new test involves collection of urine to detect the level of NGAL, which is a proven early 
marker of kidney injury. 
 
5. Do I have to pay for these tests?  
            You will have to pay for the routine tests but the special urine test is free of cost 
  
6. Does this involve free treatment during the hospital stay? 
             No, only the urine tests done for the study will be free of cost. The rest of the bill be borne by 
the family 
 
7. How many follow-up visits involved and when?  
            Two follow up visits at 3 and 6 months 
 
8. What does the follow up visit involve?  
            It involves clinical examination, blood and urine tests in both visits and a ultrasound at 6 
months 
 
9. Will my transport charges be covered for? Not applicable 
 
10. Can I withdraw from the study?  
            Yes, you can withdraw your baby from the study at anytime without giving a reason. 
 
11. Will withdrawing from the study affect the treatment?  
No, your baby will receive optimal standard of care 
 
12. Will my baby's identity be disclosed at any time?  
             No,your baby's identity will be kept confidential. At no point will his/her identify be disclosed. 
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STUDY PROFORMA 
 
Name ____________________  Hosp.No.    
Inborn       Y / N                                                 Sex            male/female/others    
  
Date of Birth                                            Time  __ __:__ __ (24 hour format) 
       
Address __________________________________________________________________ 
Contact number ___________________________________ 
Delivery: 1. Normal  2. Forceps 3.Suction Cup 4. Breech 5.LSCS 
Indication:     _____________________________________________________ 
APGAR 1 min:  ____       APGAR 5 min:  ____ 
Preterm  Y / N   Gest.Age: ________weeks 
Birth Weight: 
 
MATERNAL HISTORY    
Mother Hosp.No.     
 
Mat.Age ___________    Booked  Y / N 
Education 1. < class 6  2. Class 6 - 12   3.Graduate 4. P.G.  5. Nil 
Obstetric Score  ____________   Primipara  Y / N 
PIH  Y / N   DM  Y / N  UTI  Y / N   
Maternal medications: 
 
____________________________________________________________________________________
__________________________________________________________________________ 
 
USG:__________________ 
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Peripartum Fever Y / N  If yes, Temperature______ 
Chorioamnionitis  Y / N  Foul-smelling liquor Y / N 
MSAF    Y / N 
ROM - Spontaneous / ARM   Duration of ROM    _______ 
Prelabour ROM              Y / N  Latent period _____ hours 
Duration of Labour____ hours 
No. of PV's after ROM    
Induced                         Y / N       Induced with__________________________ 
Others 
Intrapartum antibiotics?          Y / N 
Specify:  1.______________________ 
  2.______________________ 
  3.______________________ 
 
NEONATAL RISK FACTORS 
APGAR 1 min: _______               APGAR 5 min: _________ 
Preterm  Y / N               Gest.Age: _________ ___   
Birth Weight: _________ 
Cord pH/base excess  __________ 
Blood gas pH/base excess _________ 
Onset sepsis   EOS / LOS 
Symptomatic   Y / N 
If yes, Symptomatic at birth Y / N 
    Symptomatic within few hours Y / N  How many hours? 
    Symptomatic after few days  Y / N  How many days? 
Clinical features: 
Respiratory distress  Y / N   Tachypnoea   Y / N 
Grunting   Y / N  Retractions             Y / N 
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Poor perfusion   Y / N  Shock    Y / N 
Poor feeding   Y / N  Lethargy   Y / N 
Oliguria/Anuria  Y / N  Seizures   Y / N 
Fever    Y / N  Hypothermia               Y / N 
Cellulitis   Y / N  Abcess                Y / N 
Abd. distension  Y / N  Vomiting   Y / N 
Diarhoea   Y / N  Peripheral Cyanosis             Y / N 
Others    --------------- 
Oxygen   Y / N                How many hours? ____________ 
Ventilation IMV  Y / N  CPAP   Y / N 
  How many hours? 
 FFP    Y / N   Inotropes  Y / N 
 Steroids   Y / N   IV Fluids  Y / N 
 Whole blood       Y / N   Dialysis  Y / N 
 Others    _______________ 
Risk factors for renal failure 
Resuscitation at birth                         Y / N       Intubation               Y / N 
UV line               Y / N        UA line    Y / N 
CV Cath.               Y / N       IV fluids    Y / N 
NG Tube    Y / N          PDA                                                  Y / N 
Drugs                            Y / N 
Aminoglycosides 
NSAIDS 
Other antibiotics (specify): 
Abx     X    days  Abx     X    days  Abx    X    days 
Abx    X   days  Abx     X    days  Abx    X    days 
 
 Other drugs        _________________________________ 
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Blood investigations 
Haemoglobin _______                      MCV _____________   retics ____________ 
Total count _______________  Differential counts ___________ 
Platelets _____________________ 
Electolytes – Sodium ___________  Potassium __________  Bicarbonate ___________ 
Creatinine _____________  urea ______________ 
Blood culture _________________ 
CRP ____________________ 
CSF analysis   WBC__________   P__L___   RBC______  Glu________ protein_______ 
Urine microscopy _______________________________ 
Ultrasound abdomen dated_________________________ 
ECHO ____________________________ 
Neurosonogram________________________ 
 
 Week 1 Week 2 Week 3 Week 4 
Day of life     
Creatinine      
Urine output     
Urine microscopy     
Urine NGAL     
Neonatal events     
Management      
Outcome      
 
 
OUTCOME    Discharged / Died / DAMA 
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REVIEW VISITS 
 
 3 months 6 months 
Weight gain   
NGAL   
creatinine   
Ultrasound abdomen   
Blood pressure   
Urine microscopy   
 
 
 
 
 
 
 
 
 
 
 
